Polymeric compositions and related methods of use

ABSTRACT

Adhesive polymeric compositions which can comprise dihydroxyphenyl moieties and derivatives thereof, and related methods of use.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. Ser. No. 10/199,960filed Jul. 19, 2002 which claimed priority to U.S. Ser. Nos. 60/306,750and 60/373,919 filed, respectively, on Jul. 20, 2001 and Apr. 19, 2002.This application also claims priority to U.S. Ser. No. 60/548,314 filedFeb. 27, 2004, U.S. Ser. No. 60/549,259 filed Mar. 2, 2004. Eachapplication is incorporated herein by reference in its entirety.

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

The invention was made with government support under Grant Nos.DE013030, DE012599 and DE014193 awarded by the National Institutes ofHealth and Grant No. NCC-1-02097 awarded by NASA. The government hascertain rights in the invention.

BACKGROUND OF THE INVENTION

Mussel adhesive proteins (MAPs) are remarkable underwater adhesivematerials that form tenacious bonds between mussels and the surfacesupon which the mussels reside. During the process of attachment to thesurfaces, MAPs are secreted as fluids that undergo a crosslinking orhardening reaction which leads to the formation of a solid plaque. Oneof the unique features of MAPs is the presence ofL-3,4-dihydroxyphenylalanine (DOPA), an unusual amino acid which isbelieved to be at least partly responsible for adhesion tosubstrates-through mechanisms that are not fully understood. Musselsadhere to a variety of surfaces, including metal, metal oxide, polymers,plastics, and wood.

Control of cell and protein adhesion on surfaces is critical to theperformance of biosensors, medical diagnostic products, anyinstrumentation and assays used requiring handling serum and otherhuman/animal fluids, tissue engineering, localized in vivo drugdelivery, implanted medical devices, healing of surgical incisions,adhesion of tissues such as bone and cartilage for healing, andnanotechnology (nanoparticle-based therapies and diagnostic tools). Inmany industrial applications, control of cellular and protein adhesionto surfaces is also important. Such applications include prevention ofmussel attachment to boats and ships, piers, and other structures usedin oceans and fresh water, prevention of algal and bacterial growth onwater lines used for industrial and drinking water, and sensors used tomeasure water quality and purity.

In the medical arena, the physical or chemical immobilization ofpoly(alkylene oxides) (PAO), such as polyethylene glycol (PEG),polyethylene oxide (PEO), and PEO-PPO-PEO block copolymers, such asthose available under the PLURONICS brand name, and polymers such asPEG/tetraglyme, poly(methoxyethyl methacrylate) (PMEMA), andPoly(methacryloyl phosphatidylcholine) (polyMPC) (E. W. Merrill, Ann. NYAcad. Sci., 516, 196 (1987); Ostuni et al., Langmuir 2001, 17, 5605-20,which are incorporated herein by reference) on surfaces has beenemployed as strategy to limit the adsorption of proteins and cells onsurfaces. The methods currently employed to modify surfaces withpolymers must be tailored for each type of material, and thereforerequire different chemical strategies. For example, noble metalsurfaces, such as platinum, silver, and gold, can be modified usingthiol (—SH) containing molecules, whereas metal oxides are oftenmodified using silane coupling chemistry. No surface modificationstrategy exists that can be universally applied to different classes ofmaterials. Moreover, many of the current methods rely on expensiveinstrumentation, complex synthetic procedures, or both.

SUMMARY OF THE INVENTION

The present invention are compositions which function e.g., as anadhesive, in a substantially aqueous environment. The preferredcompositions generally comprise an adhesive moiety and a polymer moiety,the polymer moiety having a desired surface active effect (or otherdesired characteristics).

In one aspect, the adhesive moiety of a composition of this inventioncomprises dihydroxyphenyl derivatives including, di (DHPD) wherein thesecond DHPD is

i.e., a methylene derivative of dihydroxy phenyl. In yet a furtheraspect, the polymer moiety comprises poly (alkyleneoxide). In a verypreferred practice, the adhesive moiety comprises DHPD, e.g., DOPA(discussed herein), and the polymer moiety comprises PEO-PPO-PEO blockpolymers (also discussed above).

In a further preferred practice the adhesive moiety comprises DHPDincluding a pendent chain comprising ethylenic or vinylic unsaturationsuch as, for example, an alkyl acrylate.

DETAILED DESCRIPTION OF THE INVENTION

Yet more specifically this invention comprises dihydroxyphenyl (DHPD)adhesive compound of formula (I) wherein

R₁ and R₂ may be the same or different and are independently selectedfrom the group consisting of hydrogen, saturated and unsaturated,branched and unbranched, substituted and unsubstituted C₁₋₄ hydrocarbon;

P is separately and independently selected from the group consisting of—NH₂, —COOH, —OH, —SH,

-   -   wherein R₁ and R₂ are defined above.    -   a single bond, halogen,

wherein A₁ and A₂ are separately and independently selected from thegroup consisting of H, a single bond;

-   -   a protecting group,    -   substantially poly(alkyleneoxide),

-   -   wherein n ranges between 1 and about 3    -   and A₃ is

-   -   -   R₄ is H, C₁₋₆ lower alkyl, or

-   -   -   R₃ is defined as above, and D is indicated in Formula (I).

In one aspect the poly(alkylene oxide) has the structure

-   -   wherein R₃ and R₄ are separately and independently H, or CH₃ and        m has a value in the range between 1 and about 250, A₄ is NH₂,        COOH, —OH, —SH, —H or a protecting group.

In a very preferred form, DHPD is

R₁, R₂, and P being defined as above.

In a further preferred form DHPD is of the structure:

-   -   wherein A₂ is —OH and A₁ is substantially poly(alkylene oxide)        of the structure

R₃, R₄ and m being defined as in claim 2. Generally speaking thepoly(alklene oxide) is a block copolymer of ethylene oxide and propyleneoxide.

A method of this invention involves adhering substrates to one anothercomprising the steps of providing DHPD of the structure:

wherein R₁ and R₂ are defined as above; applying the DHPD of the abovestructure to one or the other or both of the substrates to be adhered;contacting the substrates to be adhered with the DHPD of the abovestructure therebetween to adhere the substrates to each other, andoptionally repositioning the substrates relative to each other byseparating the substrates and recontacting them to each other with theDHPD of the above structure therebetween.

In a preferred method, R₁ and R₂ are hydrogen.

Definition: Dihydroxyphenyl derivatives (DHPD) for purposes of thisapplication shall mean dihydroxyphenyl derivatives of the followingstructure:

wherein P, R₁ and R₂ are defined below, and n ranges between 1 and about5. In one practice, R₁ and R₂ are hydrogen and P is, itself, dihydroxyphenyl. A preferred DHPD in a practice of the present invention is1-3,4, dihydroxy phenyl alanine (DOPA), (generically),

wherein A₁ and A₂ are defined above.

“Substantially poly(alkylene oxide)” as used herein shall meanpredominantly or mostly alkyloxide or alkyl ether in composition. Thisdefinition contemplates the presence of heteroatoms e.g., N, O, S, P,etc. and of functional groups e.g., —COOH, —NH₂, —SH, as well asethylenic or vinylic unsaturation. It is to be understood any suchnon-alkyleneoxide structures will only be present in such relativeabundance as not to materially reduce, for example, the overallsurfactant, non-toxicity, or immune response characteristics, asappropriate, of this polymer.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows ¹H NMR spectra of PLURONIC® F127, its carbonateintermediate (SC-PAO7) and DME-PAO7 in CDCl₃.

FIG. 2 provides differential scanning calorimetry thermograms of 30 wt %DME-PAO7, DOPA-PAO7, and unmodified PLURONIC® F127 aqueous solutions.Arrows indicate the location of gelation endotherm.

FIG. 3 plots shear storage modulus, G′, of a 22 wt % DME-PAO7 aqueoussolution as a function of temperature at 0.1 Hz and a strain of 0.45%.Shown in the inset is the rheological profile of a 22 wt %unmodified-PLURONIC® F127 aqueous solution as a function of temperature.

FIG. 4 plots shear storage modulus, G′, of a 50 wt % DME-PAO8 aqueoussolution as a function of temperature at 0.1 Hz and a strain of 0.45%.Shown in the inset is the rheological profile of a 50 wt % unmodifiedPLURONIC® F68 aqueous solution as a function of temperature.

FIG. 5 plots storage moduli of DME-PAO8 aqueous solutions at 45 wt % and50 wt %, respectively, as a function of temperature at 0.1 Hz and astrain of 0.45%.

FIGS. 6A and 6B show differential scanning calorimetry thermograms of(A) DOPA-PAO7 and (B) DME-PAO7 at different concentrations upon heating.Arrows indicate the location of gelation endotherm observed only athigher polymer concentrations.

FIGS. 7A-C show high-resolution C(1s) XPS peaks for (A) un-modified Au,(B) m-PEG-OH, and (C) m-PEG-DOPA. A dramatic increase in the ether peakat 286.5 eV in (C) indicated the presence of PEG.

FIGS. 8A-C provide TOF-SIMS positive spectrum showing peaks representingcatechol binding of gold. Spectra were normalized to Au peak (m/z ˜197).

FIG. 9 provides TOF-SIMS spectra showing the positive secondary ion peakat mass m/z ˜43 for unmodified Au substrate, Au exposed to mPEG-OH,mPEG-DOPA powder and Au exposed to mPEG-DOPA.

FIG. 10 shows TOF-SIMS spectra showing the positive secondary ion peaksfor Au substrate chemisorbed with mPEG-DOPA. Catecholic binding of goldis observed at m/z ˜225 (AuOC), 254 (AuOCCO), and 309. Less intenseAuO_(a)C_(b) peaks are seen at m/z ˜434, 450, 462, and 478. The periodictriplets seen in the m/z range 530-1150 correspond to Au bound toDOPA-(CH₂CH₂O)_(n), where each subpeak is separated by 14 or 16 amu,representing CH₂, CH₂CH₂, and CH₂CH₂O in the PEG chain. This pattern wasobserved for n=1−15.

FIG. 11 shows SPR spectra of protein (0.1 mg/ml BSA) adsorption ontomodified and unmodified gold surfaces. mPEG-DOPA and mPEG-MAPd modifiedsurfaces exhibited reduced protein adsorption compared to bare gold andmPEG-OH modified surfaces.

FIG. 12 shows mPEG-DOPA concentration dependence of anti-foulingbehavior. Gold surfaces were modified for 24 h at the mPEG-DOPAconcentrations indicated, followed by analysis of the density and areaof attached cells. (*=p<0.05, **=p<0.01, ***=p<0.001; black bars=totalproj. area, gray bars=surface cell density)

FIG. 13 compares cell attachment and spreading on bare gold,mPEG-OH-treated gold, and gold modified with mPEG-DOPA 5K, mPEG-MAPd 2K,and mPEG-MAPd 5K under optimal conditions (50 mg/ml for 24 h). (blackbars=total proj. area, gray bars=surface cell density; ***=p<0.001)

FIG. 14 A-C are a series of SEM micrographs indicating the morphology ofNIH 3T3 fibroblasts on (A) unmodified Au, (B) Au treated with mPEG-OH,and (C) mPEG-DOPA-modified Au. All treatments were at 50 mg/ml in DCMfor 24 h.

FIG. 15 shows the UV/vis absorption spectrum of mPEG-DOPA stabilizedmagnetite nanoparticles suspended in several aqueous NaCl solutions atthe concentrations as shown and plotted therein. Addition of NaCl didnot induce nanoparticle precipitation.

FIG. 16 shows addition of salt to untreated Au nanoparticles inducesaggregation. Shown are UV/vis scans of 10 nm untreated Au nanoparticlessuspended in aqueous NaCl solutions (concentrations as shown and plottedtherein). The attenuation and shift of the 520 nm absorption band withincreasing NaCl concentration reflects aggregation of the nanoparticles.

FIG. 17 illustrates addition of salt to mPEG-DOPA stabilized Aunanoparticles does not induce aggregation. Shown are UV/vis scans of 10nm mPEG-DOPA stabilized Au nanoparticles suspended in aqueous NaClsolutions (concentrations as shown and plotted therein). The lack ofattenuation and shift of the 520 nm absorption band with increasing NaClconcentration reflects effective stabilization of the nanoparticles.

FIG. 18 plots the UV/vis absorption spectrum of mPEG-DOPA stabilized CdSnanoparticles suspended in aqueous NaCl solutions (concentrations asshown and plotted therein.

FIG. 19 (plots XPS survey scans of unmodified TiO₂ and TiO₂ treated withmPEG-DOPA₁₋₃.

FIG. 20 plots the long-term resistance to cell adhesion on TiO₂ and TiO₂modified with mPEG-DOPA₁₋₃. The duration of the non-fouling response isproportional to the length of the DOPA peptide anchoring group. Adherentcells were visualized with calcium AM.

FIG. 21 plots the high-resolution XPS scans of the C1s region of TiO₂substrates modified with mPEG-DOPA₁₋₃. Of note is the increase in theether carbon peak (286.0 eV) with increasing length of the DOPA peptideanchor.

FIG. 22 plots the high-resolution XPS scans of the Ols region of TiO₂substrates modified with mPEG-DOPA₁₋₃. The peak at 532.9 eV representingpolymeric oxygen increases while the Ti—O—H peak (531.7 eV) decreaseswith increasing DOPA peptide length.

FIG. 23 plots the results of the Robust Design experiment on 316Lstainless steel.

FIG. 24 plots the 4-hour cell attachment to a variety of surfacesmodified by mPEG-DOPA₁₋₃ using a 24-hour modification at 50° C. at theindicated pHs.

FIG. 25 plots the % gel conversion versus the UV exposure time inminutes.

FIG. 26 plots the mole fraction of DOPA incorporated versus the mol % of1 or 7 in the precursor solution.

FIG. 27 plots the % gel conversion versus mol % 1 or in the precursorsolution.

FIG. 28 X-ray Photoelectron Spectroscopy XPS analysis of a siliconnitride surface.

FIG. 29 is a free monitoring of functionalized silicon nitridecantilevers.

FIG. 30 is an analysis of entropic elasticity of poly(ethylene glycol).

FIG. 31 is a force measure of side chain modified DOPA.

FIG. 32 is a proposed model of DOPA-T₁O₂ binding mechanism.

FIG. 33 is an atomic force microscopy arrangement.

FIG. 34 is data regarding force measurement.

FIG. 35 is adhesion data.

FIG. 36 is synthetic route and data analysis.

These dihydroxyphenyl derivative (“DHPD”) adhesives function in anaqueous environment. To form the polymeric composition, a DHPD moietywhich generally provides adhesive functionality coupled to a polymerwhich provides the desired surface active effect. These components willbe described in more detail below.

These adhesives and polymeric compositions have many uses, includingprevention of protein and/or cell adhesion to a surface in variousmedical, industrial and consumer applications. The DHPD adhesives canalso be used as substitutes for sutures for a wound and as aids inhealing bone fractures or cartilage-to-bone damage. These and other useswill be described in more detail below.

The preferred polymer compositions of the present invention have thefollowing structure:

wherein, for each compound of formula (1a), R₁ and R₂ are definedseparately and independently as above,

-   P₁ and P₂ are separately and independently defined as P in formula    (I); n and m independently range from 0 to about 5, provided that at    least one of n or m is at least 1;    -   Adhesive Moiety

The adhesive moiety of the present invention is a dihydroxyphenylderivative (“DHPD”) having the following preferred structure:

wherein R₁, R₂ and P are defined above and t ranges between 1 and about10, preferably about 1 to about 5 and most preferably 1 to about 3. TheDHPD adhesive can function in an aqueous environment. In this context,an aqueous environment is any medium comprising water. This includeswithout limitation water, including salt water and fresh water, cell andbacterial growth media solutions, aqueous buffers, other water-basedsolutions, and body fluids. The DHPD moiety can be derivatized. As wouldbe understood by those skilled in the art, such derivatization islimited by the retention of the desired adhesive characteristic.

Polymeric Component

Various polymeric components providing a surface active effect and otherdesired characteristics will be well-known to those skilled in the artmade aware of this invention. The desired surface active effect relatesto reduced particulate agglomeration and anti-biofouling, includingresistance to cell and/or protein adhesion. For instance, the polymercomponent can be water soluble, depending upon end-use application,and/or capable of micelle formation depending upon various other end-useapplications. Polymers useful in the present invention include, but arenot limited to, polyethylene glycol (PEG), polyethylene oxide (PEO),polypropylene oxide (PPO), PEO-PPO-PEO block copolymers, polyphenyleneoxide, PEG/tetraglyme, PMEMA, polyMPC, and perfluorunated polyethers.

The polymeric compositions can be synthesized in several ways. Forexample, the polymeric compositions may be synthesized through a generalsynthetic procedure for polymer end-group activation. Various polymersor monomeric components thereof can be activated using carbonatechemistry. In particular, a succinimidyl carbonate-activated polymericcomponent reacted with DHPD moiety can provide a stable urethaneconjugate. Two of the many possible pathways (a) and (b) in Scheme 1aand 1b, below, show coupling with a poly(alkylene oxide) in eitheraqueous or non-aqueous solvents, without compromising desiredbioadhesion. For instance, a DHPD residue can be coupled to a polymericcomponent to provide the desired conjugate composition, through eitherurethane or amide bond formation. These synthetic counts are shown inScheme 1a and 1b which are discussed in greater detail below.

More particularly, if coupled to the polymeric component via urethanebond formation, a carboxylic acid group of the DHPD component can beesterified or derivatized with various other functional groups.Alternatively, the DHPD component can be coupled to a polymericcomponent (e.g., amidation or esterification depending on polymer endgroup, —NH₂ or —OH) providing a DHPD functionality which can bederivatized by any of numerous known protecting groups, includingwithout limitation Boc, Fmoc, borate, phosphate, andtributyldimethylsilyl. N-group protection of a DHPD component can leavethe carboxylic acid group available for multi-functional derivatizationand/or a higher density of polymeric components conjugated therewith.

Accordingly, in part, the present invention is also a method of usingurethane synthesis to incorporate a DHPD residue into a polymericsystem. Such a method includes (1) providing a polymeric componentterminating in a plurality of monomers, each having a functional endgroup; (2) preparing a carbonate derivative of the polymeric component;and (3) preparing a urethane moiety upon reaction of the carbonatederivative and at least one DHPD moiety. As described above, a polymericcomponent utilized in conjunction with this method can include thosehaving terminal monomeric functionality reactive with a reagentproviding the desired carbonate derivative and, ultimately, providing aurethane moiety coupling the polymeric and DHPD components. Variousother coupling reagents and/or hydroxy-terminating polymeric componentscan be used to provide the desired urethane moiety.

In part, the present invention is also a method of using a carbonateintermediate to maintain catecholic functionality of a DHPD-incorporatedpolymeric composition and/or system, or to otherwise enhance theadhesion properties thereof. Such a method includes (1) providing apolymeric component terminating in a plurality of monomers each having afunctional end group; (2) reacting the polymeric component with areagent to provide a carbonate intermediate; and (3) reacting thecarbonate intermediate with at least one DHPD moiety. Without limitationto any single theory or mode of operation, this inventive method can beconsidered a way of enhancing the reactivity of the polymeric componentend group, via a suitable carbonate intermediate. Subsequent reaction atthe amino-nitrogen of DHPD moiety provides the corresponding conjugatewhile maintaining catecholic functionality.

In accordance with this invention, as demonstrated in Scheme 1a, varioussynthetic routes can be used to couple DHPD moieties to such carbonateactivated intermediates. DOPA methyl ester (DME), prepared by thereaction of DOPA with methanol in the presence of thionyl chloride, canbe used in organic solvents. Reaction progress can be monitored by TLCand NMR, with the coupling reaction virtually complete in one hour (withrepresentative conjugates DME-PAO7 (from PAO PLURONIC® F127) andDME-PAO8 (from PAO PLURONIC® F68)). High product yields were obtainedupon purification from cold methanol.

The free carboxylic form of DOPA can be coupled with the carbonateintermediate in alkaline aqueous solution. It is well known that thechief difficulty in working with DOPA is its ease of oxidation (toDOPA-quinone and other products), which readily occurs in alkalineaqueous solutions. To prevent unwanted oxidation of DOPA catechol sidechains during coupling under alkaline conditions, a borate-protectedDOPA can be first formed by adding DOPA to aqueous sodium borate (Scheme1b). The resulting complex is remarkably stable in neutral or alkalinesolutions, and can be readily deprotected under acidic conditions.Taking advantage of complexation between DOPA and borate, DOPA wascoupled to the ends of several commercially-available PAOs underalkaline aqueous conditions to yield DOPA-PAO7 and DOPA-PAO8. Visualinspection of the reaction solution revealed the absence of stronglyabsorbing DOPA-quinone, an indication that DOPA remains unoxidizedduring the reaction. At the completion of the reaction, acidificationwith HCl resulted in deprotection of the DOPA endgroups of the blockcopolymer.

Both ¹H NMR spectra and colorimetric assay confirmed the compositions ofthe succinimidyl activated reaction intermediates and all fourDOPA-modified PAOs of Scheme 1. Shown in FIG. 1 are ¹H NMR spectra ofPAO PLURONIC® F127, the succinimidyl carbonate activated intermediate(SC-PAO7), and the corresponding DOPA methyl ester modified PAO (usingPLURONIC® F127, DME-PAO7). The sharp peaks at ˜2.8 ppm due to the —CH₂—protons from the succinimidyl carbonate group and at ˜4.4 ppm due to the—CH₂—O— protons from the only ethylene oxide group adjacent to thecarbonate group in activated-PAO completely disappear from the ¹H NMRspectra of the DOPA-containing PAO, whereas a series of new peaks appeardue to the introduction of DOPA moieties into the copolymers. Onecharacteristic feature of the ¹H NMR spectra of the DOPA-containing PAOis the appearance of one singlet and two doublets in the range of6.5-6.9 ppm corresponding to the three protons on the DOPA phenyl ring.Similar features were also observed in the ¹H NMR spectrum (not shown)of the DOPA-PAO conjugate synthesized from aqueous solution.

Based on the assumption of two available succinimidyl carbonate groupsin the corresponding carbonate intermediates, SC-PAO7 and SC-PAO8,coupling efficiencies of DOPA methyl ester and DOPA to these two PAOswere quantitatively found to be in the range from 76% to 81% as obtainedfrom colorimetric analysis (Table 1). The reported coupling efficienciesare the average values of at least three repeated syntheses performedunder the same conditions and were not found to increase significantlywhen a larger excess of DOPA was used in the reaction. Similar couplingefficiencies were also found for DOPA-PAO7 and DOPA-PAO8 made fromaqueous solutions, suggesting that the hydrolysis of succinimidylcarbonate activated PAOs is slow in the aqueous alkaline solutioncontaining Na₂B₄O₇.

In contrast to coupling efficiencies, the product yields (shown inTable 1) of selected DOPA-modified PAOs synthesized in aqueous solutionwere found to be lower than those synthesized in organic solvent. Thismay be due to the surfactant properties of the starting PAO material,causing the low efficiency of extraction of DOPA-modified PAO withdichloromethane from water. It should be noted that the free carboxylicacid in DOPA-PAO7 and DOPA-PAO8 can be further functionalized usingstandard peptide chemistry to tailor the properties of the blockcopolymers. The four DOPA-modified PAOs of Table 1 could be stored at−20° C. indefinitely with no discoloration or change in properties.

TABLE 1 Coupling efficiency and product yield of DOPA modifiedPLURONIC ® Coupling Efficiency (%)* Product Yield (%) DME-PAO7 78.0 ±4.0 75.0 ± 5.0 DOPA-PAO7 80.0 ± 4.0 52.0 ± 3.0 DME-PAO8 76.0 ± 2.0 76.0± 4.0 DOPA-PAO8 81.0 ± 2.0 49.0 ± 2.0 *Determined by colorimetricanalysis as taught by Waite and Benedict (Waite, J. H. & Benedict, C. V.Assay of dihydroxyphenylalanine (dopa) in invertebrate structuralproteins. Methods in Enzymology 107, 397-413 (1984), which isincorporated herein by reference).

Control of cell and protein adhesion on surfaces is critical to theperformance of biosensors, medical diagnostic products, anyinstrumentation and assays used requiring handling serum and otherhuman/animal fluids, tissue engineering, localized in vivo drugdelivery, implanted medical devices, healing of surgical incisions,adhesion of tissues such as bone and cartilage for healing, andnanotechnology (nanoparticle-based therapies and diagnostic tools). Inmany industrial applications, control of cellular and protein adhesionto surfaces is also important. Such applications include withoutlimitation prevention of mussel attachment to boats and ships, piers,and other structures used in oceans and fresh water, prevention of algaland bacterial growth on water lines used for industrial and drinkingwater, and sensors used to measure water quality and purity.

The polymeric compositions of the present invention can be used ascoatings to prevent protein and cellular adhesion to devices for medicaland research applications. These include without limitation such uses ascoatings for medical implants, coatings for surgical devices, coatingsfor devices that handle serum and other animal or human derivedmaterials, medical diagnostic devices, and biosensors. Alternatively,the polymeric compositions can be tissue adhesive polymeric hydrogelsfor medical uses such as tissue sealants, gels for prevention ofsurgical adhesion (scar tissue formation), bone and cartilage adhesives,tissue engineering, and site specific drug elution and for research usessuch as immobilization of proteins including antibodies and smallmolecule analytes including pharmaceuticals. In addition, there arevarious industrial and consumer product uses of these coatings andhydrogels including without limitation prevention of marine biofouling(attachment of algae, bacteria, and mussels to surfaces underwater),prevention of bacteria contamination of water streams to industrialplants such as electronic and drug manufacturers, prevention ofbacterial contamination of drinking water streams, dental and dentureadhesives, underwater adhesives to deliver indicators, coatings forwater purity and measurement sensors, paints used for prevention ofbiofouling, and use in cosmetics to adhere desired fragrances andcolorants to hair, eyelids, lips, and skin, to form temporarily skincoloring such as tattoos and the like, and for resealable adhesives forconsumer products such as storage bags. The present methods can be usedto prepare a variety of polymer modified surfaces for both medical(diagnostics, devices, nanoparticle-based therapies) and nonmedical(paints and other particle dispersions, MEMS, quantum dots, nonfoulingsurfaces) technologies.

Adhesive hydrogels can be also formed using the present methods. TheDHPD adhesive is attached to polymers capable of forming a hydrogels invivo or in vitro. These hydrogels can be formed by a number of methodsincluding the use of self-assembling polymers that form gels at highertemperatures such as normal human body temperatures, the use of polymersthat can be cross-linked by an enzymatic reaction, the use of polymersthat can be subjected to oxidation to form cross-linked hydrogels, andthe use of polymers that can be subjected to photoactivation to producecross-linked hydrogels.

Anti-Biofouling Coatings

The anti-biofouling coatings of the present invention may be applied tomedical devices, such as vascular or arterial stents, pacemakers, heartvalves, glucose monitors and other biosensors, vascular wraps,defibrillators, orthopedics devices, and surgical devices, includingsutures and catheters. The polymeric compositions of the presentinvention can be used as coatings to prevent protein and/or cellularadhesion to a device for medical and research applications. Theseinclude without limitation such uses as coatings for medical implants,coatings for surgical devices, coatings for devices that handle serumand other animal or human derived materials, medical diagnostic devices,and biosensor. Among the challenges in modifying biomaterial surfaceswith polymers for cell adhesion resistance are producing a sufficientlyhigh density of polymer capable of repelling proteins and cells andproducing a coating that cover the surface completely. This isparticularly a problem with devices containing multiple components madeof different materials. A surface may be modified by the polymericcomposition of the present invention in any number of ways. For example,the polymeric composition may be absorbed onto the surface or a DHPDmoiety containing a polymerization initiator may be adsorbed onto thesurface and polymer growth initiated from the surface. With the latter,a number of polymerization techniques are possible, including withoutlimitation surface initiated radical polymerization, radicalpolymerization methods, ionic polymerization, ring-openingpolymerization, and photopolymerization.

For example, by utilizing the unique solubility properties of PEG, thesurface density of polymer can be increased by treating surfaces withPEG solutions near the lower critical solution temperature (LCST), orcloud point. While not wanting to be bound by theory, applicants believethat under the high ionic strength and elevated temperature conditionsused in the present invention, PEG molecules have a reduced hydrodynamicradius, which in principle allows a higher density of PEG chains to packon a surface than under standard conditions. This approach is useful forpolymers that show inverse solubility transitions at high temperatureand high ionic strength, such as poly(ethylene glycol),poly(N-isopropylacrylamide) and other N-substituted poly(acrylamides)that show inverse solubility transitions.

By modifying surfaces with various polymeric composition of the presentinvention, resistance to cell and protein attachment is conferred for upto 7 days, 14 days, 21, days, 30 days, 60 days, 90 days and 120 days orlonger. The number of DHPD moieties in the adhesive component and the pHof the modification buffer are responsible for most of the variation inthe cell and/or protein adhesion resistance of the modified materials.For those surfaces that are modified by adsorption, adsorption time andpolymeric composition concentration contributes little to the variationin cell and/or protein adhesion resistance of the modified materials.The greater the number of DHPD moiety monomers in the adhesivecomponent, the better the cell and/or protein adhesion resistance. Thedensity of the polymeric composition on the surface correlates well withresistance to cell and/or protein adhesion. The thickness of the coatinglayer can be from about 20 Å to about 100 μm, including 30 Å, dependingon the polymer composition used and the pH of the modification buffer.

The concentration of the polymer composition used for modification of asurface can be from about 0.1 mg/ml to about 75 mg/ml. The pH of themodification buffer can be from about 3 to about 9. The modificationtime can be from about 10 minutes to about 72 hours. The temperature ofthe modification can be from about 25° C. to about 60° C.

As shown in FIG. 19, XPS survey scans of unmodified TiO₂ revealed strongpeaks at ˜458 eV (Ti2p) and ˜530 eV (O1s) characteristic of nativeoxide, as well as a small peak at 248.7 eV (C1s) as a result ofadventitious hydrocarbon contamination. TiO₂ substrates treated withmPEG-DOPA₁₋₃ under cloud point conditions, however, demonstrateddramatic increases in surface-bound carbon as reflected by the C1s peak,suggesting the presence of PEG on the surface. Moreover, the increasesin the C1s peaks observed after modification with mPEG-DOPA₁₋₃ weredirectly proportional to the number of terminal DOPAs present.Additionally, a small peak at 400 eV (N1s) was seen in the spectrum ofthe TiO₂ surface modified with mPEG-DOPA₁₋₃, representing the amidenitrogen in DOPA.

Quantitative analysis of the high resolution XPS data of the substratesurfaces can provide useful information on relative amounts of PEG boundto the surface. Table 2 shows the titanium, oxygen, and carbon atomiccomposition calculations for TiO₂-modified with mPEG-DOPA₁₋₃. The oxygensignal is further subdivided into metal oxide (Ti—O—Ti), surfacehydroxide (Ti—O—H), and organic oxygen and coupled water (C—O, H₂O)species.

TABLE 2 Titanium, oxygen, and carbon atomic composition calculationsAtomic composition^(a) (wt %) O Surface Ti Ti—O—Ti Ti—O—H C—O, H₂O CUnmodified TiO₂ 31.0 47.0 7.1 3.9^(b) 11.1 MPEG-DOPA 15.5 24.5 6.2 14.938.9 MPEG-DOPA₂ 12.3 19.4 5.4 18.3 44.6 MPEG-DOPA₃ 11.5 17.3 4.7 20.645.9 ^(a)Trace amounts of N were neglected. ^(b)Assumed to be waterbound to the surface.

The ratio of Ti to Ti—O—Ti for all substrates differs substantially fromthe theoretical stoichiometry of 2.0; the difference is likely due to asampling depth that goes beyond the depth of the surface oxide (3-4 mm).This result is expected given the Flory radius of a 5000 M_(w) PEG (2.8mm) and a typical XPS sampling depth of 5-10 mm. On surfaces modifiedwith mPEG-DOPA₁₋₃, the Ti-to-C atomic ratio decreased dramatically withincreasing DOPA peptide length, corresponding to increases in the amountof adsorbed PEG. The observed C to organic oxygen (C—O) ratio exceedsthe theoretical value of 2.0 for pure PEG, which suggests thatadventitious hydrocarbon contamination remains on modified surfaces.These results are shown in Table 3.

TABLE 3 Atomic ratio for adsorbed polymeric compositions Atomic ratioSurface C/Ti Ti/Ti—O—Ti C/C—O Unmodified TiO₂ 0.36 1.51 2.84 MPEG-DOPA2.51 1.58 2.62 MPEG-DOPA₂ 3.62 1.57 2.43 MPEG-DOPA₃ 4.01 1.51 2.24

DOPA creates strong, reversible bonds with TiO₂. The energy of the bondis 30.56 kcal/mol and needs about 800 pN to be detached from TiO₂ at thesingle molecule level, which is four times stronger than the interactionbetween Avidin and Biotin. The DOPA-TiO₂ strength of interaction isabout midway between that of Avidin-Biotin, one of the strongesthydrogen bond based interactions in biology (0.1-0.2 nN) and a covalentbond (>2nN).

To study DOPA adhesion properly, the following conditions were used:single molecule approach, an aqueous environment, and a platform forDOPA immobilization. Atomic Force Microscopy (AFM) was chosen as a toolfor the investigation which satisfies those three conditions and issensitive enough to measure the viscoelastic properties of softmaterials: protein, DNA, and synthetic polymers at a single moleculelevel. Amine moieties were introduced to a cantilever tip (Si3N4) andthen the mixture of methoxy-poly(ethylene glycol, mPEG) andFmoc-terminated PEG (Fmoc-PEG) derivatives were conjugated. (Boc-)DOPAwas coupled to the amine groups generated by the cleavage of Fmoc (FIG.33C). A 5˜10 molar excess of mPEG to DOPA-PEG was used so that single,immobilized DOPA4 PEG could be isolated. This molecular configurationsterically hindered the molecular dynamics of DOPA-PEG, thus providingan explanation for the result of DOPAoxidation experiments later (FIG.36). Chemical reaction steps were monitored by X-ray photoelectronspectroscopy (XPS) showing successful PEG modifications on flat siliconnitride surfaces (1×1 cm2) (FIG. 28). Chemical groups introduced ontosilicon nitride tip surfaces change electrostatic properties, which arealso good indicators of surface modifications (FIG. 29-A). It isimportant to note that the difference of approaching signals wasdetected between bare and modified cantilevers representing resistanceforce due to molecular layers (FIG. 29-B).

DOPA conjugated cantilevers displayed significant adhesion accompaniedby entropic elasticity of the PEG chain (FIG. 34). A histogram of theforce distribution shows a uni-modal shape indicating only singleadhesive event, which is different compared to the case of a multivalentprotein, Avidin12. Force-Distance (F-D) measurements were collected anda statistical analysis performed (FIG. 34, n=105). The average force was785 pN in water at a loading rate of 180 nN/s. Most importantly, thelength of stretched PEG (36 nm) was consistent with the expected contourlength of a PEG molecule (37 nm, FIG. 30). These data are observing asingle molecular event: monovalent binding of DOPA, polydispersity ofPEGs, and tip geometry. A single DOPA was conjugated at the end of apolymer chain, to serve as one binding unit on a TiO2 surface (FIG. 33).This monovalency is different from metal-Histidine6 (Metal-(His)₆)studies where tethered (His)₆ provides three metal chelating sites (3×metal/(His)₂)13-15. In addition, a ‘mountain-tree’ like configuration ofPEG5 antilever can separate two different DOPA detachment signalsbecause of polydispersity of PEGs (tree) and the spherically-shaped tip(mountain) (r=25 nm).

Defined, “d” is the z-displaced distance of piezoelectric device when asingle DOPA-PEG molecule was fully stretched during retraction (FIG.34C). The ‘d’ values appeared to be almost constant throughout manyrepeated cycles although it did vary slightly (FIG. 34A). This smallvariation might be due to DOPA binding to the surface at differentangles. An important feature of our experiment is that the unbindingsignals are epetitions using the ‘identical’ DOPA molecule. This iscompared to the traditional approach of single molecule pullingexperiments where tips picked up one molecule randomly. This alsodemonstrates that the DOPA adhesion chemistry was completely reversible.This reversibility led us to the conclusion that the weakest chemicallinkage from substrate to tip (TiO2˜Si3N4) is the Ti(surface)-O(DOPA)bond.

The result suggested that at ˜0.8 nN, the DOPA-TiO2 interaction ismechanically midway between that of Avidin-Biotin, one of the strongesthydrogen bond-based interaction in biology (0.1˜0.2 nN) and covalentbond (>2 nN). Energy information from force data by changing the loadingrate, the amount of force applied per unit time. Changes over fourorders of magnitude of a loading rate generated four different forcedistributions to map the energy landscape of DOPA binding. Linear-logline plot of force vs. loading rate in FIG. 34D provided binding energyand a distance after which the association is removed along the appliedforce direction. DOPA had an energy barrier of 28.1 kcal/mol, and thedistance needed to reach the activation energy maximum was 1.27 Å (FIG.34E).

The binding orientation of DOPA is believed to be with the two hydroxylgroups on the aromatic ring pointed down toward the surface. Therefore,the confirmation of chemical groups responsible for single moleculeadhesion signals in AFM is important to exclude other binding chemistrydue to different orientations. Two methods were used.

First, chemical modification of the hydroxyl group covalently byertarybutyldimethylsiloxane, (TBDMS) resulted in no binding during twohundred approach-retraction cycles (FIG. 31 first line). However,deprotection of the TBDMS groups regenerated the binding ability of DOPA(FIG. 31, bottom two lines).

Second, the protection by ionic complexation with borate completelysuppressed the strong adhesion of DOPA as well (FIG. 31, n=200). Thesedata clearly confirmed the di-hydroxyl group of DOPA as the truestructural source for strong and reversible binding.

Mussels developed an interesting way to create such a strong binding inwater, a post-translational modification of tyrosine by tyrosinehydroxylase. This enzyme catalyzes a reaction of adding one hydroxylgroup using tyrosine as a substrate and a large amount is found inthreads and plaques where DOPA exists as well. It is surprising to saythat the small post-translational modification (—OH) seems to produce ahuge change of adhesive ability. Thus, experiments were designed to showa correlation between the posttranslational modification and bindingability.

A tyrosine tethered cantilever was prepared instead of DOPA, andtyrosine adhesion on TiO2 was investigated. No detectable force signalswere observed except some non-specific adhesions with low probability(FIG. 35A). To reject the hypothesis that the tip used in thisexperiment didn't have any tyrosine molecules, the TiO2 surface wasreplaced with gold. The aromatic ring of tyrosine binds to a goldsurface in a parallel orientation to the surface through π-π electroninteraction, which is a well-known mechanism in surface adsorptionchemistry 18,19. The same cantilever used in TiO2 produced relativelystrong adhesions repeatedly on gold surfaces (FIG. 35B). The statisticalanalysis of force distribution showed the 7α-1 electron binding strengthof 398 (±98) pN which was about 50% strength compared to the DOPA-TiO2interaction (FIG. 35C). The force signals from tyrosine-gold bindingalso exhibited the same characteristics as previously shown in DOPA-TiO2interaction: elastic stretching of PEG with an expected contour lengthand repetitive signal appearance with similar ‘d’ (FIG. 33C). In thisexperiment, it was clearly proved that the tyrosine hydroxylase-mediatedpost-translational modification greatly improved the binding ability ofDOPA from almost zero to 800 pN.

Biological roles of DOPA go beyond adhesiveness upon oxidation: itcrosslinks polypeptide chains resulting in stiffer materials foundthroughout threads and pads. The crosslinking mechanism has multiplepathways starting from a chemically unstable DOPAquinone structure.Aryl-aryl ring coupling (di-DOPA) has been found in mussel adhesiveproteins₂₀ but Michael addition (quinone-alkylamine adducts) productshave been found in other species not mussels (FIG. 36A). Therefore,these structures may occur as results of oxidation in mussels as well.It is clear in terms of crosslinking but is under debate with respect toadhesive properties after maturation i.e. oxidation. It was demonstratedthat the DOPAquinone structure is not a major player for adhesiveness.The DOPAquinone-PEG chain is spatially and chemically stabilized byexcess co-conjugation of methoxy-PEG molecules (5˜10 molar equivalent)which is an important molecular configuration for preventing furtherreactions of DOPAquinone.

Time-resolved monitoring force signals of single DOPAquinone triggeredby increasing pH (=9.7) uncovered interesting things that have beenhidden so far. First, measured AFM signals showed two cleardistributions in terms of force magnitude: high force and low force(FIG. 36B). Statistical analysis of the data yielded two clearhistograms with 178±62 pN for low and 741±110 pN for high force (FIG.36C). The quinone binding can be assigned to the low force regionbecause it appeared only after the oxidation was triggered andsubsequently became more frequent over time (FIG. 36D). The slow kineticfeature of DOPA oxidation contributed to initial high frequency of DOPAsignals. This is the first single molecule experiment about detectingthe structural change of a small molecule upon external stimulus. Basedon these results, the possibility of the DOPAquinone structure beingresponsible for the high adhesiveness can be ruled out. Therefore,without being bound to any theory, the regeneration of reduced form i.e.di-hydroxyl group of DOPA during oxidation, is believed to be a veryimportant requirement for maintaining or changing adhesive properties ofDOPA containing materials at an interface.

In addition, the DOPA anchoring system can be a new platform to studyother extensible biological macromolecules such as polysaccharides, DNA,and proteins. In the study performed, it already presented the elasticproperty of PEG (Mw 3400) and is believed to be the shortest chainlength ever studied until now. This could be achievable simply becausetwo defined anchoring methods were used at both ends: (1) covalent bondsbetween PEG and cantilever and (2) DOPA anchoring between PEG andsubstrate. This method is also highly contrasted with the conventionalsingle molecule experiments where a tip ‘sees’ different molecules atevery single movement of a cantilever. It has been a big barrier toinvestigate molecular responses upon external stimuli if a givenstimulus was not hundred percent effective_(23,). The DOPA-basedanchorage system can be an alternative technique to overcome theseproblems in current single molecule pulling experiments.

Currently, there is no clear answer why DOPA behaves like a reversibleglue similar to ‘Post-It’. Two molecular binding models, nomonuclearbidentate (FIG. 32A, right) and binuclear bidentate (FIG. 32A, left),are available but both did not consider the reversible binding of DOPAbecause the studies focused on only adsorption processes notdesorption₂₅. Therefore, the nature of chemical binding was assumed tobe mainly covalent independent of factors resulting from the removal ofwater molecules after adsorption. One study using FTIR suggested thatthe nature of DOPA-TiO2 binding may be 60% ionic and 40% covalent. Basedon this finding, a the molecular adsorption models were revised toincorporate the reversibility where multiple hydrogen bonds are formedin water (FIG. 32B)

FIG. 33 An Experimental Design and a Single Molecular DOPA Adhesion

A picture describes how the blue mussel (Mytilus Edulis) sticks to metaloxide surfaces. The circle included one plaque where the unusual aminoacid, DOPA, was found.

(B) Two major protein components uncovered in plaques in mussels, Mefp-3and Mefp-5. These mussel adhesive proteins have high content of DOPA: 27mole % of Mefp-5 and 21% of Mefp-3. Bold Y (Y): DOPA, Italic S(S):phospho-serine, Italic R(R): hydroxyarginine.

(C) AFM tip modifications. Polymerization of3-aminopropyltrimethoxysilane (APTMS) introduced amine groups on Si3N4tip surfaces (not drawn). A long chain describes a PEG moleculeconjugated with single (Boc)-DOPA at the end. Mixture of mPEG-NHS(2k)and Fmoc-PEG-NHS(3.4k) at a molar ratio of 5˜10:1 was used to stabilizeDOPA-PEG molecule (see supplemental section for details).

FIG. 34. Single molecule Force Measurement and Determination of EnergyLandscape of DOPA Binding on TiO2 Surfaces

Four representative AFM single molecule DOPA detachment signals from onecantilever. Those four signals were not consecutively generated (signalswere deleted which didn't show any adhesions). Despite a low probabilityto detect DOPA adhesion (5˜10%), detected signals showed similar ‘d’values (refer to FIG. 34C).

(B) A histogram describing the distribution of force. Average is 781±151pN (n=105) at a loading rate of 180 nN/sec.

(C) A definition of the distance, ‘d’, the z-directional moving distanceof a piezoelectric device when DOPA-PEG molecule is fully stretched

(D) A plot of bonding strength (linear) vs. loading rate (log). Loadingrate was the product of spring constant of a cantilever and a pullingspeed. Four different loading rates were selected: 1500, 180.7, 28.4 and2 nN/sec. Averaged forces with standard deviation were plotted at eachgiven loading rate. Forces were 846.48±157 pN (1500 nN/s), 781±151 pN(180 nN/s), 744±206 pN (28.4 nN/s), and 636.2±150 (2 nN/s).

(E) A schematic energy landscape of DOPA binding. External force tiltedthe landscape and lowered the energy barrier from the reactioncoordinates. The slope (=kBT/xb) of the linear regression plot was 32.31resulting in the distance to activation barrier (xb) was 1.27 Å. Theenergy barrier height was determined by extrapolation when a loadingrate equals to zero (Eb=28.1 kcal/mol).

FIG. 35. Molecular Identification of the Adhesive Origin of DOPA

Single molecule adhesion of tyrosine on TiO2 surfaces. No clear bindingsignals were detected (upper representative signal, n=639 out of 700repeats) except the initial electrostatic interactions which wereunavoidable in some cantilevers. Nonspecific adsorption signals (lowerrepresentative signal, n=61 out of 700).

(B) Confirmation of tyrosine existence on the tip surface. Pi (π)electrons of tyrosine phenyl group specifically interact with goldπ-electron.

(C) Force distributions of tyrosine binding to a gold surface. Tyrosinepresented 398±98 pN (180 nN/sec) adhesion strength.

FIG. 36. The Change of DOPA Adhesiveness Upon Oxidation (DOPAquinone)

A schematic chemistry pathway of the formation and oxidation of DOPA.DOPA was created by the action of tyrosine hydrxylase and subsequentlyoxidized to DOPAquinone by pH and the enzyme. It is unstable andreactive due to tendency of radical formation of DOPAquinone. It cancrosslink with other DOPA molecules (di-DOPA) as well as reacts withamine groups from lysines. The arrows are the potential reactions foundin other species not in mussel adhesive proteins.

(B) Representative force signals (n=16) with similar ‘d’ defined in FIG.1C (˜50 nm). They were collected for 1 hr AFM experiment (1800 repeats)in a basic condition (20 mM Tris-Cl, pH 9.7). Time progress makes fromthe top to bottom of the graph. Red signals indicate DOPA-TiO2 and blacksignals for DOPAquinone-TiO2

(C) Force histograms after total analysis of 1800 F-D curves. Thehistogram at a low force region showed 178±82 pN (n=143) and the one ata high force region exhibited 741±110 pN (n=51).

(D) A scatter plot of the number of events during a specified timewindow (10 min). DOPA signals (circle, left y-axis) gradually decreasedfrom twenty-two events for the first ten minutes to only three eventsduring the last time window. However, quinone signals (triangle, righty-axis) increased from one event at the first time window to forty-twoevents at the last time window (50˜60 min).

To summarize, successfully measured the single molecule binding strengthof DOPA (˜0.8 nN) was successfully measured, and the reversible bindingchemistry was shown. This strong adhesion was created bypost-translational modification but was significantly reduced byoxidation of DOPA, to DOPAquinone.

The antifouling coating of the present invention can either beessentially permanent i.e., lasting 120 days or more, or biodegradeabledepending on the number of DOPA or DOPA-derived moieties in the adhesivecomponent. FIG. 20 shows the results of a 28-day 3T3 fibroblast celladhesion and spreading assay on TiO₂ treated with mPEG-DOPA₁₋₃. At earlytime points (i.e. less than 7 days), the protein and cell attachmentresistance correlates well with the length of the DOPA peptide anchoringgroup, with resistance increasing in the ordermPEG-DOPA<mPEG-DOPA₂<mPEG-DOPA₃. TiO₂ substrates treated with mPEG-DOPA₂and mPEG-DOPA₃ maintain reduced cell attachment, or resistance, through21 days.

Robust design methodology was used to determine the effect of DOPApeptide anchor length and modification conditions (pH, concentration andtime) on the PEG surface density and antifouling performance of metal,metal oxide, semiconductor, and polymer surfaces. The nine experimentsutilized for each substrate are described below in Table 7. For nearlyall surfaces, the length of the DOPA peptide and the pH of themodification buffer lead to the largest variation in the amount of PEGabsorbed, as measured by XPS and the adhesion and spreading of 3T3fibroblasts. The experiments summarized in Table 7 permitted thedetermination of modification conditions that provided optional celladhesion resistance for a variety of materials, as measured by 4-hourcell attachment assays. After the nine experiments were performed oneach substrate, the data was subjected to Robust Design analysis. Thepresence of large error values when plotting Robust Design data is acharacteristic of the technique since a single data point at one factorlevel contains the variation of the remaining factors averaged over allthe levels.

The polymeric compositions of the present invention can be also used tocoat the surfaces of devices and instrumentation used for handling bodyfluids including sera. The coating on the surface of the device orinstrument blocks protein binding to the surfaces thus reducing oreliminating the need for extensive washing or cleaning of the device orinstrument between uses. The devices need to be thoroughly cleaned toprevent cross contamination between samples of bodily fluids applied topthe device. Presently, the cleaning of these instruments and devicebetween uses requires extensive washing with caustic agents such as 50%bleach and/or elevated temperatures. The coating process would be tocirculate an aqueous solution of 1 mg/ml of DHPD polymer through thedevice at room temperature for a period of a few hours.

The coatings of the present invention can be used on medical implantsfor a wide variety of uses. For example, the coatings can be used toblock bacterial adhesion and therefore growth on the implanted devicereducing the possibility of infection at the site of implant. Thecoatings can be used to reduce the amount of acute inflammation on thedevice by reducing protein binding and cell adhesion to the device. Thecoatings of the present invention can also be used as nanoparticles toprevent aggregation of these particle in the presence of serum.

Hydrogels

The polymeric compositions of the present invention can also be assurgical adhesives for medical and dental uses and as vehicles for drugdelivery to mucosal surfaces. The polymeric compositions can be used astissue adhesive polymeric hydrogels for medical uses such as tissuesealants, gels for prevention of surgical adhesions (scar tissueformation), bone and cartilage adhesives, tissue engineering, and sitespecific drug elution and for research uses such as immobilization ofproteins including antibodies and small molecule analytes includingpharmaceuticals. The polymeric compositions of the present invention mayalso be used as interfacial bonding agents, wherein the neat monomers orsolution of monomers are applied to a surface as a primer or bondingagent between a tissue surface or a metal or metal oxide implant/devicesurface and a bulk polymer or polymer hydrogel. With an appropriatepolymer component, which one of ordinary skill in the art couldidentify, the polymeric compositions of the present invention can beinjected or delivered in a fluid form and harden in situ to form a gelnetwork. The in situ hardening can occur through photocuring, chemicaloxidation, enzymatic reaction or through the natural increase intemperature resulting from delivery into the body.

In part, the present invention is also a method for the non-oxidativegelation of a polymeric composition of the present invention. One suchmethod includes (1) providing a polymeric composition of the presentinvention; (2) admixing water and the polymeric composition; and (3)increasing admixture temperature sufficient to gel the polymericcomposition, such temperature increase without oxidation of the polymeror DOPA or DOPA-derived moiety residue incorporated therein. Dependingupon choice and identity of the polymer component of such a composition,an increase in admixture concentration can reduce the temperaturerequired to effect gelation. Depending upon choice and identity of aparticular copolymer component, a larger hydrophilic block thereof canincrease the temperature required to gel the corresponding composition.Various other structural and/or physical parameters can be modified totailor gelation, such modifications as can be extended to otherpolymeric compositions and/or systems which are consistent with thebroader aspects of this invention.

It is widely acknowledged that the commercially-available PLURONIC®block copolymers self-assemble in a concentration- andtemperature-dependent manner into micelles consisting of a hydrophobicPPO core and a water-swollen corona consisting of PEO segments. At highconcentration, certain PEO-PPO-PEO block copolymers, such as PLURONIC®F127 and PLURONIC® F68, transform from a low viscosity solution to aclear thermoreversible gel at elevated temperature. While not wanting tobe bound by theory, it is generally assumed that the interactionsbetween micelles at elevated temperature lead to the formation of a gelphase, which is stabilized by micelle entanglements. The micellizationand gelation processes depend on factors such as block copolymermolecular weight, relative block sizes, solvent composition, polymerconcentration, and temperature. For example, increasing the length ofthe hydrophilic PEO blocks relative to the hydrophobic PPO block resultsin an increase in micellization and gelation temperature (T_(gel)).

Differential scanning calorimetry (DSC) measurements were performed onaqueous solutions of DME-PAO7 and DOPA-PAO7 at different concentrationsto detect aggregation of block copolymers into micelles. DSC profilesobtained for PLURONIC® F127, DME-PAO7 and DOPA-PAO7 were found to bequalitatively similar and were characterized by a large endothermictransition corresponding to micelle formation followed by a smallendotherm at T_(gel) (FIG. 2). The transition temperature of the smallpeak was found to correlate strongly with T_(gel) determined byrheometry and the vial inversion method (Table 4).

TABLE 4 Gel temperatures obtained from vial inversion method, rheologyor differential scanning calorimetry for 22 wt % DME-PAO7, DOPA-PAO7 andPLURONIC ® F127 solutions. Gel Temperature (° C.) vial inversion methodRheological DSC DME-PAO7 (22 22.0 ± 1.0 20.3 ± 0.6 20.9 ± 0.1 wt %)DOPA-PAO7 (22 22.0 ± 1.0 20.4 ± 0.5 21.7 ± 0.2 wt %) PLURONIC ® F12717.0 ± 1.0 15.4 ± 0.4 17.5 ± 0.4 (22 wt %)

Aqueous solutions with concentrations ranging from 10 to 30% (w/w) ofDOPA-PAO7 copolymers and 35 to 54% (w/w) of DOPA-PAO8 copolymers wereprepared by the cold method, in which DOPA conjugate was dissolved indistilled water at about 4° C. with intermittent agitation until a clearsolution was obtained. Thermal gelation of concentrated solutions wasinitially assessed using the vial inversion method. In this method, thetemperature at which the solution no longer flows is taken as thegelation temperature.

The gelation temperature was found to be strongly dependent on copolymerconcentration and block copolymer composition (i.e., PAO7 versus PAO8).For example, 22 wt % solutions of DOPA-PAO7 and DME-PAO8 were found toform a transparent gel at approximately 22.0±11.0° C.; decreasing thepolymer concentration to 18 wt % resulted in a gelation temperature ofapproximately 31.0±1.0° C. However, DOPA-PAO7 solutions withconcentrations less than 17 wt % did not form gels when heated to 60° C.DOPA-PAO7 exhibits a slightly higher gel temperature than that(17.0±1.0° C.) of unmodified PLURONIC® F127. The gelation behavior ofDOPA-PAO8 was found to be qualitatively similar, except that much higherpolymer concentrations were required to form a gel. 54 wt % solutions ofDOPA-PAO8 and DME-PAO8 formed gels at 23.0±1.0° C., while 50 wt % ofDOPA-PAO8 gels at 33.0±1.0° C. However, DOPA-PAO8 solutions withconcentrations less than 35 wt % did not form gels when heated to 60° C.DOPA-PAO8 exhibits a much higher gel temperature than that (16.0±1.0°C.) of unmodified PLURONIC® F68. These gels were found to be resistantto flow over long periods of time. From this experiment, we have alsofound that both DOPA and DOPA methyl ester-derivatives of the samecommercially available PLURONIC® PAO exhibit almost the same geltemperature, and the gel made from 54 wt % of either DME-PAO8 orDOPA-PAO8 at room temperature is stiffer than that made from 22 wt % ofeither DME-PAO7 or DOPA-PAO7.

The viscoelastic behavior of DOPA-modified PLURONIC® solutions wasfurther studied by oscillatory rheometry. FIG. 3 shows the elasticstorage modulus, G′, of 22 wt % solutions of unmodified PLURONIC® F127and DME-PAO7 aqueous solutions as a function of temperature. Below thegelation temperature, storage modulus G′ was negligible, however G′increased rapidly at the gel temperature (T_(gel)), defined as the onsetof the increase of the G′ vs. Temperature plot. DOPA-PAO7 (not shown)exhibited a similar rheological profile. The T_(gel) of 22 wt %solutions of DME-PAO7 and DOPA-PAO7 were found to be identical(20.3±0.6° C.), which is approximately 5 degrees higher than anequivalent concentration of unmodified-PLURONIC® F127 (15.4±0.4° C.). G′of DME-PAO7 or DOPA-PAO7 approaches a plateau value of 13 kPa, which iscomparable to that of unmodified PLURONIC® F127.

Shown in FIG. 4 are the rheological profiles of 50 wt % solutions ofunmodified PLURONIC® F68 and DME-PAO8 as a function of temperature. TheT_(gel) of a 50 wt % DME-PAO8 solution was found to be 34.1±0.6° e,whereas the T_(gel) of an equivalent concentration of unmodifiedPLURONIC® F68 was approximately 18° C. lower (16.2±0.8° C.). The plateaustorage moduli of 50 wt % solutions of DME-PAO8 and unmodified PLURONIC®F68 were not significantly different, approaching a plateau value ashigh as 50 kPa. The concentration dependence of T_(gel) is illustratedin FIG. 5, which shows the rheological profile of DME-PAO8 at twodifferent concentrations as a function of temperature. T_(gel) of 45 wt% solution of DME-PAO8 was observed to be approximately 12° C. higherthan that of 50 wt % solution of DME-PAO8.

Since both DOPA and DOPA methyl ester can be considered hydrophilic, theincrease of T_(gel) observed in the DOPA-modified PLURONIC® PAOs,compared with that of unmodified PLURONIC® PAOs, is likely due to theincrease in length of the hydrophilic PEO segments resulting fromcoupling of DOPA to the endgroups. It is clear from the data shown inFIGS. 3 and 4 that the coupling of DOPA or DOPA methyl ester to thePLURONIC® PAO endgroups has a more significant impact on the T_(gel) ofPLURONIC® F68 compared to PLURONIC® F127. This can be rationalized interms of the overall molecular weights of F68 (approx. 8,600) and F127(approx. 12,600). Addition of DOPA and DOPA methyl ester to bothendgroups using the chemistry shown in Scheme 1 results in an increasein molecular weight of 446 and 474, respectively. This represents alarger % molecular weight increase for F68 compared to F127, due tolower base molecular weight of F68.

The data presented herein is in agreement with previous calorimetrystudies of unmodified PLURONIC® PAOs, which demonstrated that the broadpeak at low temperature is due to micellization while the small peak athigher temperature, only observed in concentrated solutions, correspondsto gelation, a nearly athermal process. As seen in Table 5, the onsettemperature of micellization, the temperature at maximum heat capacityand T_(gel) of unmodified PLURONIC® F127 were found to be lower thanthose of DOPA-PAO7, whereas the specific enthalpies determined from theareas under the transition (FIG. 2) are approximately the same. Theseenthalpies include contributions from both micellization and gelation.However, due to the small enthalpy of gelation, the observed enthalpychanges can be largely attributed to micellization.

TABLE 5 Comparisons of 30 wt % DME-PAO7, DOPA-PAO7 and unmodifiedPLURONIC ®F127 solutions on onset micellization temperature, temperatureat maximum heat capacity, enthalpies, and gel temperature fromdifferential scanning calorimetry experiments Temp. at MicellizationMax. heat ΔH Gel Temp. temp.(° C.) capacity (° C.) (J/g) (° C.) DME-PAO75.2 ± 0.2 8.3 ± 0.1 20.3 ± 2.4 14.0 ± 0.4 (30 wt %) DOPA-PAO7 (30 4.6 ±0.2 8.0 ± 0.6 19.3 ± 1.4 14.0 ± 0.2 wt %) PLURONIC ® 1.9 ± 0.3 6.0 ± 0.420.6 ± 1.6 10.6 ± 0.6 F127 (30 wt %)

The micellization peak was seen to extend to temperatures above theonset of gelation, indicating that additional monomers aggregate intomicelles at temperatures above the gelation point. The concentrationdependence of DOPA-PAO7 and DME-PAO7 aggregation is shown in FIG. 6. DSCthermograms indicate a decrease in micellization temperature and T_(gel)with increasing polymer concentration. The broad endothermic peakcorresponding to micellization can also be observed in solutions atconcentrations at which no gelation takes place; the characteristictemperature of the broad peak increases linearly with decreasingcopolymer concentration, whereas the small peak was observed to coincideto the gel temperature of the concentrate copolymers but disappears ascopolymer concentration decreases.

As can be gathered from the preceding, various polymeric compositions ofthis invention can be designed and prepared to provide variousmicellization and/or thermal gelation properties. Alternatively, or inconjunction therewith, degradation into excretable polymer componentsand metabolites can be achieved using, for instance, polyethylene glycoland lactic/glycolic acids, respectively. Regardless, the polymericcompositions of this invention provide improved adhesion byincorporation of one or more DHPD residues, such incorporation resultingfrom the coupling of a terminal monomer of the polymeric component tosuch a residue.

Another method of non-oxidative gelation of a polymeric composition ofthe present invention is photocuring. A photocurableDHPD-moiety-containing monomer is copolymerized with PEG-DA(PEG-diacrylate) to form adhesive hydrogels through photopolymerization.Photopolymerization can be achieved at any visible of UV wavelengthdepending on the monomer used. This is decidedly determined by oneskilled in the art. The photocurable monomers consist of an adhesivemoiety coupled to a polymerizable monomer with a vinyl group, such as amethacrylate group with or without an oligomeric ethylene oxide linkeror fluorinated ether linker in between.

An aqueous mixture of a photopolymerizable monomer containing anadhesive of the present invention and PEG-DA and 1.5 μL/mL of aphotoinitiator, such as 2,2′-dimethoxy-2-phneyl-acetonephenone (DMPA),camphorquinone/4-(dimethylamino)-benzoic acid (CQ/DMAB), and ascorbicacid/fluorescein sodium salt (AA/FNa₂) was irradiated using a UV lamp(365 nm), for more than 5 minutes. Presence of the adhesive in theprecursor solution was found to affect the radical polymerizationprocess. The catechol adhesive decreased the extent of gel formation,reduced the percent of adhesive incorporation in the gel network, andlengthened the gel formation time.

As shown in FIG. 25, gel conversion as determined by measuring the massof the sondgel, reached more than 75 wt % after 2 minutes of UVirradiation and increased to greater than 85 wt % upon irradiation formore than 5 minutes. Gelation of PEG-DA occurred in 4 minutes or lesswhen visible light initiators were used (4 minutes for CQ/DMAB and 3minutes for AA/FNa₂).

Copolymerization of PEG-DA with 1 or 7 (syntheses of 1 and 7 are shownin Schemes 2 and 3) was qualitatively similar to polymerization of purePEG-DA, although addition of 1 or 7 to the PEG-DA precursor solutionresulted in a decrease in gel conversion that was dependent on DOPAmonomer concentration and initiating system. For example, inDMPA-initiated UV polymerization, gel conversion was reduced to lessthan 85 wt % in the presence of 2.5 mol % or more of 1 or 7. However,the extent of gel conversion was not statistically different between thegels. Similar DOPA concentration dependent inhibition was observed forthe visible light induced initiators. For AA/FNa₂ and CQ/DMAB initiatedmixtures, addition of 33.3 mol % of 1 increased the gelation time tomore than 8 minutes. Nevertheless, solutions containing 1 and 7 werestill capable of photocuring even at a relatively high mol % of DOPA.

For example, 53.8 mol % of either 1 or 7 in the precursor solutionreduced the gel weight % from 88 to 77 and only 85 mol % of the DOPA wasincorporated into the hydrogel. A colorimetric DOPA assay developed byWaite and Benedict performed on the photocured hydrogels revealed thepresence of catecholic DOPA in the hydrogel. After photocuring,DOPA-containing gels were dialyzed in 0.5 N HCl to extract unreactedDOPA monomer. To quantify the extent of DOPA incorporation, thedialysate was analyzed according to the DOPA calorimetric assay of Waiteand Benedict and the results were used to calculate the amount of DOPAincorporated into the gel network. FIG. 26 shows the mole fraction ofDOPA incorporated into the gel network, as a function of mol % monomer 1and 7 in the precursor solution. There was no significant difference inthe mole fraction of DOPA incorporated between samples containing 1 and7. As much as 24.9 μmol/g of DOPA was incorporated into the PEGhydrogels.

Direct evidence for the presence of DOPA in the gels was obtained byimmersing the intact dialyzed hydrogels in nitrite reagent followed byNaOH. The initially colorless gels turned bright yellow after theaddition of the nitrite reagent and then red following the addition ofexcess base. This color transition is typical of catechols, indicatingthat the unoxidized form of DOPA was incorporated into the hydrogelsthrough photopolymerization. The intensity of the red color alsoreflects the concentration of DOPA incorporated into the photocuredgels.

Contact mechanical tests were performed on the photocured gels in theshape of hemispheres to obtain information on the mechanical propertiesof the gels. Elastic moduli (E) were calculated by assuming Hertzianmechanics for the specific case of non-adhesive contact between anincompressible elastic hemisphere and a rigid plane, in which case theHertzian relationship between load (P_(h)) and displacement (δ_(h))becomes:

$\begin{matrix}{P_{h} = {\frac{16R^{1/2}E}{9}\delta_{h}^{3/2}}} & (1)\end{matrix}$where R is the radius of curvature of the hemispherical gel. Load versusdisplacement data was fitted with Equation (1), which allowed theelastic moduli to be calculated based on the proportionality factor ofthe curve fit. As seen in Table 6, average Young's moduli (E) forDOPA-containing gel of around 50 kPa was obtained.

TABLE 6 Average Young's Moduli for DOPA containing gels DOPA Content*Young's Modulus (μmol/g gel) (kPa) Average Std. Dev. Average Std. Dev.PEG-DA 72.3 7.69 PEG-DA + 1⁺ 15.0 0.25 47.4** 8.63 PEG-DA + 7⁺ 14.50.056 51.4** 9.91 ⁺33 mol % in the precursor solution *Determined fromDOPA assay **p < 0.001 relative to PEG-DA gels

These modulus values are about 30% lower than that of PEG-DA gels,confirming the inhibitory effect of DOPA on radical photopolymerization.Despite the decrease in modulus compared to PEG-DA gels, DOPA-containinggels still exhibited moduli suitable for many biomedical applications. Asuitable modulus is one greater than 500 Pa. Another use of the adhesivehydrogels is for localized drug delivery. For example, adhesivehydrogels can be formed on a mucous membrane in the mouth or oralcavity. The hydrogels can be loaded with a drug such as an antibioticand facilitate slow release of the drug over a period of time. Theyhydrogel can also be loaded with an analgesic and used to deliver painrelief at a localized site. They hydrogel can also be loaded with achemotherapy drug and inserted into malignant tissue to deliverlocalized cancer therapy. The hydrogel can also be loaded with a cellproliferation inhibitor therapeutic drug and used as a coating stent orother vascular device and used to control cell proliferation at the siteof an implant of the vascular device.

A tissue adhesive hydrogel capable of being cross-linked in vivo can beused as a tissue sealant for replacing metal or plastic sutures. Theadhesive bends to the surrounding tissue at a surgical or injury siteand the polymer forms a cohesive link to close the wound. The hydrogelcan also be used for repair of bone fractures and cartilage to bonedamage.

Other Uses

There are various industrial product uses of these coatings andhydrogels including prevention of marine biofouling (attachment ofalgae, bacteria, and mussels to surfaces underwater), prevention ofbacteria contamination of water streams to industrial plants such aselectronic and drug manufacturers, prevention of bacterial contaminationof drinking water streams, dental and denture adhesives, underwateradhesives to deliver indicators, coatings for water purity andmeasurement sensors, paints used for prevention of biofouling.

There are also a number of consumer product and cosmetic uses of thesecoatings and hydrogels including without limitation use in dental anddenture adhesives, use in cosmetics for adhesive to hair, skin, andlegs, use in cosmetics such as eye shadow, lip stick, and mascara, usein application of temporary tattoos, and use as resealable adhesives forbags and containers.

Without limitation to any particular synthetic scheme or method ofpreparation, suitable compositions of this invention can include but arenot limited to a urethane moiety between each such terminal monomer andDOPA residue. As described more fully below, such a moiety is asynthetic artifact of the agent/reagent utilized to couple the DOPAresidue with the polymeric component. Within the broad aspects of thisinvention, various other moieties are contemplated, as would beunderstood by those skilled in the art made aware of this invention,depending upon terminal monomer functionality and choice of couplingagent.

EXAMPLES General Description

The following non-limiting examples and data illustrate various aspectsand features relating to the compositions and/or methods of the presentinvention, including the production of various polymeric or co-polymericcompositions having incorporated therein one or more DHPD components, asare available through the synthetic methodology described herein. Whilethe utility of this invention is illustrated through the use of severalpolymeric or co-polymeric systems, it will be understood by thoseskilled in the art that comparable results are obtainable with variousother compositions and/or methods for preparation, as are commensuratewith the scope of this invention.

PEO₁₀₀PPO₆₅PEO₁₀₀(PLURONIC® F127, avg. M_(w)=12,600), PEO₇₈PPO₃₀PEO₇₈(PLURONIC® F68, avg. M_(w)=8,400), PEG (avg. M_(w)=8000),pentafluorophenol, 1,3-dicyclohexylcarbodiimide (DCC),4,7,10-trioxa-1,13-tridecanediamine, fluorescein sodium salt (FNa₂), andascorbic acid (AA) were purchased from Sigma (St. Louis, Mo.). L-DOPA,thionyl chloride, methacroyloyl chloride, t-butyldimethylsilyl chloride(TBDMS-Cl), di-t-butyl dicarbonate, methacrylic anhydride,2,2′-dimethoxy-2-phenyl-acetonephenone (DMPA), acryloyl chloride,1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), tetrabutylammonium fluoride(TBAF), 4-(dimethylamino)-benzoic acid (DMAB), 1-vinyl-2-pyrrolidone(VP), N,N-disuccinimidyl carbonate, sodium borate, sodium molybdatedihydrate, sodium nitrite, 4-(dimethylamino)pyridine (DMAP),N-hydroxysuccinimide, N,N-diisopropylethylamine, dimethylformamide, anddichloromethane were purchased from Aldrich (Milwaukee, Wis.).Camphorquinone (CQ) was obtained from Polysciences, Inc. (Warrington,Pa.). Acetone was dried over 4 Å molecular sieve and distilled over P₂O₅prior to use. Triethylamine was freshly distilled prior to use. Allother chemical reagents were used as received.

L-DOPA methyl ester hydrochloride was prepared according to theprocedure of Patel and Price, J. Org. Chem., 1965, 30, 3575, which isincorporated herein by reference. Succinimidyl propionate activated PEG(mPEG-SPA, avg. M_(w)=5000) was obtained from Shearwater Polymers, Inc.(Huntsville, Ala.). Ethyl acetate saturated with HCl was prepared bybubbling HCl gas through ethyl acetate (50 mL) for approximately 10minutes. 3,4-Bis(t-butyldimethylsiloxyl)L-phenylalanine (DOPA(TBDMS)₂)and 3,4-bis(t-butyldimethylsiloxyl-N-t-butoxycarbonyl-L-phenylalanine(Boc-DOPA(TBDMS)₂) were synthesized according to the method of Sever andWilker, Tetrahedron, 2001, 57, (29), 6139-6146, which is incorporatedherein by reference.

Glass coverslips (12 mm dia.) used in the following examples werecleaned by immersing in 5% Contrad70 solution, a detergent which is anemulsion of anionic and nonionic surfactants in an allealtine aqueousbase (Decon Labs, Inc., Bryn Mawr, Pa.) in an ultrasonic bath for 20minutes, rinsed with deionized (DI) H₂O, sonicated in DI H₂O for 20minutes, rinsed in acetone, sonicated in acetone for 20 minutes, rinsedin hexanes, sonicated in hexanes for 20 minutes, rinsed in acetone,sonicated in acetone for 20 minutes, rinsed in DI H₂O, and sonicated inDI H₂O for 20 minutes. The coverslips were subsequently air-dried in aHEPA-filtered laminar flow hood. To create pristine gold substrates,clean coverslips were sputtered (Cressington 208HR) with 2 nm Crfollowed by 10 nm Au (99.9% pure).

Titanium oxide (TiO₂) surfaces were prepared by electron beam physicalevaporation onto silicon (Si) wafer and cleaned in a plasma chamberprior to testing. Si wafers (MEMC Electronic Materials, St. Peters, Mo.,surface orientation (100)) were coated with 100 nm Ti by an EdwardsFL400 electron beam evaporator at <10⁻⁶ Torr. The Si wafer was then cutinto 8 mm×8 mm pieces which were subsequently cleaned by ultrasonicationin the following media: 5% Contrad70, ultrapure water (ultrapure wateris deionized and distilled), acetone, and petroleum ether. Thesubstrates were further cleaned in an oxygen plasma chamber (HarrickScientific, Ossining, N.Y.) at <200 mTorr and 100 W for 3 minutes.

Both pristine and modified gold surfaces were characterized, asdescribed below, by X-ray photoelectron spectroscopy (XPS). XPS data wascollected on an Omicron ESCALAB (Omicron, Taunusstein, Germany)configured with a monochromated AlKα (1486.8 eV) 300-W X-ray source, 1.5mm circular spot size, a flood gun to counter charging effects, and anultrahigh vacuum (<10⁻⁸ Torr). The takeoff angle, defined as the anglebetween the substrate normal and the detector, was fixed at 45°.Substrates were mounted on standard sample studs by means ofdouble-sided adhesive tapes. All binding energies were calibrated usingeither the Au(4f_(7/2)) gold peak (84.0 eV) or the C(1s) carbon peak(284.6 eV). Analysis consisted of a broad survey scan (50.0 eV passenergy) and a 10-minute high-resolution scan (22.0 eV pass energy) at270-300 eV for C(1s). Peak deconvolution and atomic percent calculationswere performed with EIS analysis software.

Secondary ion spectra were collected on a TRIFT III™ time-of flightsecondary ion mass spectrometer (TOF-SIMS) (Physical Electronics, EdenPrairie, Minn.) in the mass range 0-2000 m/z. A Ga⁺-source was used at abeam energy of 15 keV with a 100 μm raster size. Both positive andnegative spectra were collected and calibrated with a single set of lowmass ions using the PHI software Cadence.

To determine relative hydrophilic/hydrophobic nature of the surfaces,contact angle data was collected, as described below, by the sessiledrop method. A custom-built contact angle goniometer (components fromRamé-Hart, Mountain Lakes, N.J.) equipped with a humidified samplechamber was used to measure both advancing and receding contact anglesof ultrapure water (18.2MΩ-cm; Bamstead, Dubuque, Iowa) on unmodifiedand modified substrates. For each surface, four measurements were madeat different locations and the mean and standard deviation werereported.

Surface Plasmon Resonance (SPR) measurements were made on a BIACORE 2000(Biacore International AB; Uppsala, Sweden) using bare gold sensorcartridges. The resonance response was calibrated using 0-100 mg/ml NaClsolutions. Dilute solutions (0.1 mM in H₂O) of mPEG-DOPA, mPEG-MAPd, andmPEG-OH were injected into the SPR flow cell for 10 minutes after whichflow was switched back to pure DI H₂O. In a separate experiment tomeasure protein adsorption to modified substrates, sensor surfaces withpreformed PEG films were exposed to 0.1 mg/ml bovine serum albumin (BSA)solution in 10 mM HEPES buffer (0.15 M NaCl, pH=7.2), and subsequentlypure buffer.

For use in demonstration of anti-fouling effects, NIH 3T3-Swiss albinofibroblasts obtained from ATCC (Manassas, Va.) were maintained at 37° C.and 10% CO₂ in Dulbecco's modified Eagle's medium (DMEM; Cellgro,Herndon, Va.) containing 10% (v/v) fetal bovine serum (FBS) and 100 U/mlof both penicillin and streptomycin.

RP-HPLC preparation was performed using a Waters HPLC system (Waters,Milford, Mass.) on a Vydac 218TP reverse phase column with a gradient ofacetonitrile/0.1% trifluoroacetic acid (v/v) water. ESI-MS analysis wasperformed on a LCQ LC-MS system (Finnigan, Thermoquest, CA). MALDI-TOFMS analysis was performed on a Voyager DE-Pro mass spectrometer(Perseptive Biosystem, MA). α-Cyano-4-hydroxycinnaminic acid was used asa matrix. NiTi alloy (10 mm×10 mm×1 mm) was obtained from NitinolDevices & Components (Fremont, Calif.). Si, SiO₂ (1500 Å thermal oxide),and GaAs wafers were purchased from University Wafer (South Boston,Mass.).

With regard to the following cell adhesion tests and/or spreadingassays, modified and unmodified substrates were pretreated in 12-wellTCPS plates with 1.0 ml of DMEM containing 10% FBS for 30 minutes at 37°C. and 10% CO₂. Fibroblasts of passage 12-16 were harvested using 0.25%trypsin-EDTA, resuspended in DMEM with 10% FBS, and counted using ahemocytometer. Cells were seeded at a density of 2.9×10³ cell/cm² bydiluting the suspension to the appropriate volume and adding 1 ml toeach well. The substrates were maintained in DMEM with 10% FBS at 37° C.and 10% CO₂ for 4 hours, after which time unattached cells wereaspirated. Adherent cells on the substrates were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently treated with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI;Molecular Probes, Eugene, Oreg.) in DMSO for 30 minutes at 37° C. Thestain was then aspirated and substrates were washed (3×) with DMSO for10 minutes and mounted on glass slides using Cytoseal (StephensScientific, Kalamazoo, Mich.) to preserve fluorescence. Theseexperiments were performed in triplicate for statistical purposes. Forelectron microscopy, some samples were dehydrated with EtOH afterfixing, critical-point dried, and sputtered with 3 nm Au.

To quantify cell attachment, substrates were examined with an OlympusBX-40 (λ_(Ex)=549 nm, λ_(Em)=565 nm) and color images were captured witha Coolsnap CCD camera (Roper Scientific, Trenton, N.J.). Five imageswere taken from each of the three substrate-replicates. The resultingimages were quantified using thresholding in MetaMorph (UniversalImaging, Downington, Pa.). A one-way ANOVA and Tukey's post-hoc testwith 95% confidence intervals (SPSS, Chicago, Ill.) were used todetermine statistical significance of the data. The mean and standarddeviation of the measurements were reported.

Example 1 Synthesis of Succinimidyl Carbonate PAO, SC-PAO7

PLURONIC® F 127 (0.60 mmols) was dissolved in 30 mL of dry dioxane.N,N′-Disuccinimidyl carbonate (6.0 mmols) in 10 mL dry acetone wasadded. DMAP (6.0 mmols) was dissolved in 10 mL dry acetone and addedslowly under magnetic stirring. Activation proceeded 6 hours at roomtemperature, after which SC-PAO7 was precipitated into ether. Thedisappearance of the starting materials during the reaction was followedby TLC in chloroform-methanol (5:1) solvent system. The product waspurified by dissolution in acetone and precipitation with ether fourtimes. The product yield was 65%. ¹H NMR (500 MHz, CDCl₃): δ ppm0.96-1.68 (br, —OCHCH₃CH₂O—), 2.80 (s, —COON(CO)₂(CH₂)₂), 3.15-4.01 (br,—OCH₂CH₂O—; —OCHCH₃CH₂O—), 4.40 (s, —OCH₂CH₂OCOON(CO)₂CH₂CH₂—).

Example 2 Synthesis of DME-PAO7

A slurry of DOPA methyl ester hydrochloride (1.25 mmols) andtriethylamine (2.5 mmols) was mixed with SC-PAO7 (0.16 mmols) in 10 mLchloroform. The disappearance of the starting materials during thereaction was followed by TLC in chloroform-methanol-acetic acid (5:3:1)solvent system. After stirring for 1 hour at room temperature, thesolvent was evaporated off, and DME-PAO7 was purified by precipitationfrom cold methanol three times. DME-PAO7 gave a positive Arnow testindicating the presence of catechol hydroxyl groups. The product yieldwas 75%.

¹H NMR (500 MHz, CDCl₃): δ ppm 0.98-1.71 (br, —OCHCH₃CH₂O—), 2.83-3.06(m, —NHCHCH₂C₆H₃(OH)₂COOCH₃), 3.15-4.02 (br, —OCH₂CH₂O—;—NHCH(CH₂C₆H₃(OH)₂COOCH₃), 4.05-4.35 (d,—OCH₂CH₂OCONHCHCH₂C₆H₃(OH)₂COOCH₃), 4.55 (br, —NHCHCH₂C₆H₃(OH)₂COOCH₃),5.30 (d, —NHCHCH₂C₆H₃(OH)₂COOCH₃), 6.45-6.80 (1s, 2d,—NHCHCH₂C₆H₃(OH)₂COOCH₃).

Example 3 Synthesis of DOPA-PAO7

L-DOPA (1.56 mmols) was added to 30 mL 0.1 M Na₂B₄O₇ (pH=9.32) aqueoussolution under Ar atmosphere, followed by stirring at room temperaturefor 30 minutes. SC-PAO7 (0.156 mmols) in 5 mL acetone was added to theresulting mixture and stirred overnight at room temperature. Thesolution pH was maintained with sodium carbonate during the reaction.The disappearance of the starting materials during the reaction wasfollowed by TLC in chloroform-methanol-acetic acid (5:3:1) solventsystem. The solution was acidified to pH 2 with concentratedhydrochloric acid and then extracted three times with dichloromethane.The combined dichloromethane extracts were dried with anhydrous sodiumsulfate and filtered, and dichloromethane was evaporated. The productwas further purified by precipitation from cold methanol. DOPA-PAO7 gavea positive Arnow test indicating the presence of catechol hydroxylgroups. The product yield was 52%. ¹H NMR (500 MHz, CDCl₃): δ ppm0.92-1.70 (br, —OCHCH₃CH₂O—), 2.91-3.15 (m, —NHCHCH₂C₆H₃(OH)₂COOCH),3.20-4.10 (br, —OCH₂CH₂O—; —OCHCH₃CH₂O—), 4.1-4.35 (d,—OCH₂CH₂OCONHCHCH₂C₆H₃(OH)₂COOH), 4.56 (m, —NHCHCH₂C₆H₃(OH)₂COOH), 5.41(d, —NHCHCH₂C₆H₅(OH)₂COOH), 6.60-6.82 (1s, 2d, —NHCHCH₂C₆H₃(OH)₂COOH).

Example 4 Synthesis of Succinimidyl Carbonate PAO8, SC-PAO8

A procedure similar to that described above for the synthesis andpurification of SC-PAO7 was used to prepare SC-PAO8. The product yieldwas 68%.

¹H NMR (500 MHz, CDCl₃): δ ppm 0.95-1.58 (br, —OCHCH₃CH₂O—), 2.80 (s,—COON(CO)₂(CH₂)₂), 3.10-4.03 (br, —OCH₂CH₂O—; —OCHCH₃CH₂O—), 4.40 (s,—OCH₂CH₂OCOON(CO)₂CH₂CH₂).

Example 5 Synthesis of DME-PAO8

A procedure similar to that described above for the synthesis andpurification of DME-PAO7 conjugate was used to make DME-PAO8. Theproduct yield was 76%. ¹H NMR (500 MHz, CDCl₃): δ ppm 0.98-1.50 (br,—OCHCH₃CH₂O—), 2.85-3.10 (m, —NHCHCH₂C₆H₃(OH)₂COOCH₃), 3.15-4.01 (br,—OCH₂CH₂O—; —OCHCH₃CH₂O—; —NHCH(CH₂C₆H₃(OH)₂COOCH₃), 4.03-4.26 (d,—OCH₂CH₂OCONHCHCH₂C₆H₃(OH)₂COOCH₃), 4.55 (m, —NHCHCH₂C₆H₃(OH)₂COOCH₃),5.30 (d, —NHCHCH₂C₆H₃(OH)₂COOCH₃), 6.45-6.77 (1s, 2d,—NHCHCH₂C₆H₃(OH)₂COOCH₃).

Example 6 Synthesis of DOPA-PAO8

A procedure similar to that described above for the synthesis ofDOPA-PAO7 conjugate was used to prepare and purify DOPA-PAO8. Theproduct yield was 49%. ¹H NMR (500 MHz, CDCl₃): δ ppm 0.92-1.50 (br,—OCHCH₃CH₂O—), 2.91-3.10 (m, —NHCHCH₂C₆H₃(OH)₂COOH), 3.15-3.95 (br,—OCH₂CH₂O—; —OCHCH₃CH₂O—), 4.06-4.30 (d, —OCH₂CH₂OCONHCHCH₂C₆H₃(OH)₂COOH), 4.54 (m, —NHCHCH₂C₆H₃(OH)₂COOH), 5.35 (d,—NHCHCH₂C₆H₅(OH)₂COOH), 6.50-6.80 (1s, 2d, —NHCHCH₂C₆H₃(OH)₂COOH).

Example 7 Colorimetric Assay

Coupling efficiencies of DOPA methyl ester and DOPA to PLURONICs® F 127and F68 were determined using the colorimetric method of Waite andBenedict. Briefly, samples were analyzed in triplicate by dilutingaliquots of standards or unknown solutions with 1 N HCl to a finalvolume of 0.9 mL. 0.9 mL of nitrite reagent (1.45 M sodium nitrite and0.41 M sodium molybdate dihydrate) was added to the DOPA solution,followed immediately by the addition of 1.2 mL of 1 N NaOH. Due totime-dependent changes in absorbance intensity, care was taken to ensurethat the time between the addition of NaOH and recording of theabsorbance was 3 minutes for all standards and samples. The absorbancewas recorded at 500 nm for all standards and samples. DOPA was used asthe standard for both the DOPA methyl ester and DOPA conjugates.

Example 8 Rheology

Rheological measurements of the gelation process were performed using aBohlin VOR Rheometer (Bohlin Rheologi, Cranbury, N.J.). A 30 mm diameterstainless steel cone and plate geometry with a cone angle of 2.5 degreeswas used for all measurements. The temperature was controlled by acirculating water bath. Samples were cooled in the refrigerator prior totransfer of 0.5 mL of liquid solution to the apparatus. Measurements ofstorage and loss moduli, G′ and G″, were taken in the oscillatory modeat 0. I Hz and a strain of 0.45%. The heating rate was 0.5° C./minexcept in the vicinity of the gelation temperature, when it was reducedto 0.1° C./min. The strain amplitude dependence of the viscoelastic datawas checked for several samples, and measurements were only performed inthe linear range where moduli were independent of strain amplitude.Mineral oil was applied to a ring surrounding the outer surfaces of thesample compartment to prevent dehydration during measurements.

Example 9 Differential Scanning Calorimetry (DSC)

DSC measurements were performed on a TA Instruments DSC-2920 (TAInstruments, New Castle, Del.) calorimeter. Spectra were obtained forthree samples of each concentration on heating and cooling cycle. Samplevolumes of 20 μl in hermetically sealed aluminum pans were used andscans were recorded at a heating and cooling rate of 3° C./min with anempty pan as reference.

Example 10a

Amino-terminated methoxy-PEG, mPEG-NH₂ (2.0 g, 0.40 mmoles, M_(w)=2,000or 5,000, Sun-Bio PEGShop), N-Boc-L-DOPA dicyclohexylammonium salt (0.80mmoles), HOBt (1.3 mmoles), and Et₃N (1.3 mmoles) were dissolved in 20mL of a 50:50 mixture of dichloromethane (DCM) and DMF. HBTU (0.80mmoles) in 10 mL of DCM was then added, and the reaction was carried outunder argon at room temperature for 30 minutes. The reaction solutionwas successively washed with saturated sodium chloride solution, 5%NaHCO₃, diluted HCl solution, and distilled water. The crude product wasconcentrated under reduced pressure and purified by columnchromatography on Sephadex® LH-20 with methanol as the mobile phase. Theproduct, mPEG-DOPA, was further purified by precipitation in coldmethanol three times, dried in vacuum at room temperature, and storedunder nitrogen at −20° C. ¹H NMR (500 MHz, CDCl₃/TMS): δ 6.81-6.60 (m,3H, C₆H₃(OH)₂—), 6.01 (br, s, 1H, OH—), 5.32 (br, s, 1H, OH—), 4.22 (br,s, 1H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 3.73-3.38 (m, PEO), 3.07 (m, 2H,PEO-CH2—NH—C(O)—), 2.73 (t, 2H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 1.44 (s,9H, (CH₃)₃C—), 1.25 (s, 3H, CH₃CH₂O—).

Example 10b

The synthesis and related procedures of the preceding example can beextended, by analogy, using other DOPA-containing peptides andoligopeptides, whether natural or synthetic in origin. Depending upon aparticular synthetic sequence, use of an N-terminal protecting group maybe optional. As referenced above, various other DOPA-like adhesivecomponents can also be utilized, as would be well-known to those skilledin the art made aware of this invention. For instance, B-amino acids andN-substituted glycine DOPA analogs can be used.

Regardless of a particular DHPD adhesive component, a variety ofpolymeric components can be used in accordance with the synthetictechniques and procedures described above. The polymeric component canvary in molecular weight limited only by corresponding solubilityconcerns. As mentioned above, a variety of other polymers can be usedfor surface anti-fouling and/or particle stabilization, such polymersincluding but not limited to hyaluronic acid, dextrans and the like.Depending upon solubility requirements and desired surface effect, thepolymeric component can be branched, hyperbranched or dendrimeric, suchcomponents available either commercially or by well-known synthetictechniques.

While the composition of Example 10a is the amidation product of thereferenced starting materials, it should be understood that comparablepolymer-DHPD conjugates can be prepared coupling the N-terminus of aDHPD component to an end group, back bone or side chain of a suitablyfunctionalized natural or synthetic polymer, including those describedabove. For example, and without limitation, as illustrated above, asuitable polymeric component terminating with a carbonate functionalitycan be used to provide the desired conjugate by reaction with theN-terminus of the desired DHPD component.

Example 11a

The consensus decapeptide repeat sequence (mussel adhesive proteindecapeptide, MAPd, NH₂-Ala-Lys-Pro-Ser-Tyr-Hyp-Thr-DOPA-Lys-CO₂H) of theblue mussel Mytilus edulis foot protein 1 (Mefp 1) was synthesized bysolid phase peptide synthesis on Rink resin (0.6 mMol/g) using Fmocprotected amino acids, BOP, HOBt, and DIEA as activating agents, and NMPas solvent. Fmoc deprotection was performed using a 25% piperidinesolution in NMP for twenty minutes. Couplings of amino acids wereperformed using two equivalents of the Fmoc-amino acid BOP:HOBt:DIEA ina 1:1:1:1 ratio for twenty minutes, with an initial, ten-minutepreactivation step. Upon completion of the decapeptide, the free amineterminus of the decapeptide was coupled to activated methoxy-PEG-CO₂H(mPEG-SPA, M_(w)=2k or 5k, Shearwater Polymers) using carbodiimidechemistry. The PEG-decapeptide conjugates (mPEG-MAPd, 2k or 5k) werecleaved at 0° C. for two hours using 1 M TMSBr in TFA, with EDT,thioanisole, and m-cresol. The crude mPEG-MAPd products wereprecipitated in ether at 0° C., and purified by preparative HPLC using aVydac 218TP reverse phase column (220×22 mm×10 μm). The purity of theproducts was determined to be >90% using analytical HPLC, and thestructures confirmed using a PerSeptive Biosystem MALDI-TOF-MS.

Example 11b

The synthesis and procedures of Example 11a can be extended analogous toand consistent with the variations illustrated in Example 10b. Inaddition, other conjugates can be prepared using DOPA-containingpolymers prepared by enzymatic conversion of tyrosine residues therein.Other techniques well-known in the field of peptide synthesis can beused with good effect to provide other desired protein sequences,peptide conjugates and resulting adhesive/anti-fouling effects.

Example 12a

Gold surfaces were modified by adsorption of mPEG-DOPA or mPEG-MAPd (2k,5k) from solution in DCM or phosphate-buffered saline (PBS; pH=3, 7.4,and 11) at polymer concentrations ranging from 0.1-75 mg/ml. Substrateswere placed in a vial and immersed in mPEG-DOPA or mPEG-MAPd solutionfor up to 24 hours without agitation. Upon removal from solution,substrates were rinsed with the appropriate solvent (DCM or DI H₂O) toremove unbound polymer, and dried in vacuo. For comparison, identicalsurface modifications were performed using PEG-monomethylether (mPEG-OH,avg. M_(w)=5000). Alternatively, a drop of solution containing mPEG-DOPAor mPEG-MAPd (10 mM in PBS, PEG molecular weight=2000) was incubated ona Au-coated glass coverslip (Au thickness ˜10 nm) for 30 minutes at 37°C., after which the surface of the coverslip was rinsed (3×) with PBS.Analysis of the modified surfaces by advancing/receding contact angle,XPS, and TOF-SIMS revealed the formation of a chemisorbed layer ofmPEG-DOPA or mPEG-MAPd.

FIGS. 7A-C shows the XPS spectra for the unmodified, mPEG-OH modified,and mPEG-DOPA modified surfaces. As expected, the ether peak at 286.5 eVincreased only slightly with the mPEG-OH treatment, while a dramaticincrease was observed after adsorption of mPEG-DOPA, indicating a largepresence of ether carbons. An ether peak from a pure PEG with the samebinding energy has been reported in the literature. The smaller peak at285.0 eV in FIG. 7 can be attributed to the aliphatic and aromaticcarbons in the PEG and DOPA headgroup, as well as some hydrocarboncontamination resulting from the preparation/evacuation process.

Time-of-flight SIMS data corroborated the XPS findings. TOF-SIMSanalysis was carried out on unmodified and mPEG-DOPA-modified Ausubstrates, as well as mPEG-DOPA powder and a gold substrate exposed tomPEG-OH. Data was collected from each substrate for about 4 minutes.

The positive ion spectrum of unmodified Au exhibits (CnH_(2n+1))⁺ and(C_(n)H_(2n−1))⁺ peaks, typical for hydrocarbon contamination (data notshown). Additional minor contaminants were present, including NH₄ ⁺,Na⁺, and relatively small amounts of C_(a)H_(b)O_(c) ⁺ species. Becauseof the process used to deposit the Au film, a peak for Cr was seen atm/z ˜52, in addition to the Au peak at m/z ˜196.9. Exposing the goldsurfaces to mPEG-OH resulted in only modest increases in the peaksrepresenting C_(a)H_(b)O_(c) ⁺ PEG fragments, which are likelyattributable to contamination or non-specific absorption of mPEG-OH.This is evidenced by the peaks at m/z ˜225 (AuOC⁺) and 254 (AuOCCO⁺)which did not show dramatic increases when compared to substratesmodified with mPEG-DOPA. (FIGS. 8A-C).

The positive ion spectrum of the Au surface modified with mPEG-DOPA wasdominated by the presence of C_(a)H_(b)O_(c) ⁺ peaks representing theadsorbed molecule. As illustrated in FIG. 9, the relative abundance ofC₂H₃O⁺ and C₂H₅O⁺ increased with respect to unmodified and mPEG-OHmodified surfaces. There was also a dramatic increase in the relativeabundance of C₃H₇ ⁺ (m/z ˜43) and C₄H₅ ⁺ (m/z ˜53), as well, which canlikely be attributed to hydrocarbon contamination or the fragmentationof the t-butyl in the Boc protection group.

Perhaps the most notable feature of the positive ion spectrum of thePEGylated Au substrate were the patterned triplet repeats in the highmass range (FIG. 10). Each of these triplet clusters corresponds to anAu-DOPA-(CH₂CH₂O)_(n) fragment. When further resolved, each subclusterwithin the triplet represents the addition of CH₂, CH₂CH₂, or CH₂CH₂O,as each of these peaks is about 14-16 amu apart. This repeat pattern wasidentifiable from n=0−15, beyond which the signal was below detectablelimits.

In the negative ion spectra for the pristine Au surface, little of notewas observed aside from the strong definable peaks for O⁻, HO⁻, andAu_(n) ⁻ for n=1−3 (data not shown). There was a small amount ofhydrocarbon contamination present at m/z ˜13 (CH—), 24 (C₂H₂—), and 37(C₃H—). The negative ion spectrum of the PEGylated Au surface wasdominated by the peak for C₇H₁₁O₂ ⁺ at m/z 126.893. The presence of thispeak at modest intensity in the spectrum of the mPEG-OH modified Ausuggests that it represents a larger ethylene glycol fragment. The mostinteresting peaks lie in the high mass range (>200 m/z) and representthe coupling of catecholic oxygen to Au. The spectrum suggests that oneAu atom can bind up to six oxygen atoms, corresponding to three DOPAs.

The contact angle data demonstrated a firm dependence on the characterof the adsorption solvent used when modifying the gold films withmPEG-DOPA (data not shown). The surface modified in DCM showed asignificantly lower θa than the unmodified surface (p<0.001) and thesurfaces modified in all aqueous solutions (p<0.05). Generally speaking,as the pH of the aqueous solutions was increased, the hydrophilicity ofthe treated surfaces was decreased, indicating a diminished ability toPEGylate the surfaces, perhaps due to the propensity of DOPA to beoxidized to its less adhesive quinone form at elevated pH, aninterpretation that is supported by previous studies that showed theunoxidized catechol form of DOPA is primarily responsible for adhesion.

Example 12b

Protein adsorption and attachment/spreading of cells onto untreated andtreated coverslips were evaluated as follows. Surface plasmon resonance(SPR) experiments demonstrated that the DOPA-containing polymers wererapidly bound to the gold surface and the resulting modified surfacespossessed an enhanced resistance to protein adsorption (FIG. 11).Protein adsorption onto mPEG-MAPd (5k) modified gold was roughly 70%less than to the unmodified gold surface. Analysis of fibroblastscultured on modified substrates showed a strong dependence of cellattachment on mPEG-DOPA concentration (FIG. 12), adsorption solvent, andmodification time used during preparation of the PEG-modifiedsubstrates. Surfaces modified for 24 hours with >25 mg/ml mPEG-DOPA ormPEG-MAPd exhibited a statistically significant reduction in cellattachment and spreading (FIGS. 12-14). The mPEG-MAPd (5k) modified goldsurface exhibited a 97% reduction in total projected cellular area and a91% reduction in the density of cells attached to the surface.

Example 12c

The modification illustrated in Example 12a, optionally varied asreferenced in Examples 10b and 11b, can be extended to other noblemetals, including without limitation, silver and platinum surfaces. Suchapplication can also be extended, as described herein, to includesurface modification of any bulk metal or metal alloy having apassivating or oxide surface. For example, bulk metal oxide and relatedceramic surfaces can be modified, as described herein. Such techniquescan also be extended to semiconductor surfaces, such as those used inthe fabrication of integrated circuits and MEMS devices, as alsoillustrated below in the context of nanoparticulate stabilization.

Example 13

Silicate glass surfaces (glass coverslips) were modified by adsorptionof mPEG-MAPd (2k) from a 10 mM solution in water, using the methoddescribed in Example 12a. The cell density of NIH 3T3 cells attached tomodified and unmodified glass surfaces were evaluated as described,above. Glass surfaces modified for 24 hours with mPEG-MAPd exhibited a43% reduction in cell density compared to unmodified glass surfaces(Cell Density (cells/mm²): 75.5+/−6.5 on unmodified glass; 42.7+/−9.8 onmPEG-MAPd modified glass).

Example 14a

To illustrate stabilization of metal oxides and, in particular, metaloxide nanoparticles, 50 mg of mPEG-DOPA (5k) was dissolved in water (18MΩ-cm, Millipore) and combined with 1 mg of magnetite (Fe₃O₄) powder.Similar preparations were also prepared using a mPEG-NH₂ (5k) (Fluka)and a mPEG-OH (2k) (Sigma) as controls. Each of these aqueous solutionswas sonicated using a Branson Ultrasonics 450 Probe Sonicator for onehour while being immersed in a 25° C. bath. The probe had a frequency of20 kHz, length of 160 mm, and tip diameter of 4.5 mm. The sample wasthen removed and allowed to stand at room temperature overnight to allowany unmodified magnetite to precipitate out of solution. Suspensionsprepared using the control polymers (mPEG-NH₂ and mPEG-OH) rapidlyprecipitated to yield a brown solid and clear, colorless supernatant. Insamples prepared using PEG-DOPA stabilized nanoparticles, the sample wasclear and brown. The clear brown supernatant was isolated and dialyzedfor three days in water using Spectra/Por® membrane tubing(MWCO:15,000). Following dialysis, the sample was lyophilized and storedunder vacuum at room temperature until used.

Example 14b

mPEG-DOPA stabilized nanoparticles were characterized by transmissionelectron microscopy (TEM), thermogravimetric analysis (TGA), fouriertransform infrared spectroscopy (FTIR), and UV/vis spectroscopy. TEMresults demonstrated that the majority of nanoparticles were of diameterof 5-20 nm (data not shown). TGA analysis of 0.4 mg of mPEG-DOPAstabilized magnetite indicated that the particles contain 17% by weightmPEG-DOPA (data not shown). FTIR performed on untreated magnetite showedrelatively little absorbance within the wavelength range from 4000-400cm⁻¹, whereas the mPEG-DOPA treated nanoparticles exhibited absorptionbands at 800-1600 cm⁻¹ and 2600-3200 cm⁻¹, confirming the presence ofmPEG-DOPA.

Example 14c

The dry PEG-DOPA stabilized magnetite nanoparticles readily dispersed inaqueous and polar organic solvents (e.g., dichloromethane) to yieldclear brown suspensions that were stable for months without theformation of noticeable precipitates. Suspensions of mPEG-DOPAstabilized nanoparticles in various solvents were prepared by dispersing1 mg of mPEG-DOPA treated magnetite in 1 ml of water (18 MΩ-cm filteredusing a Millex® AP 0.22 μm filter (Millipore)), DCM or Toluene.Suspensions were placed in a bath sonicator for ten minutes to dispersethe nanoparticles. All three solutions were stable at room temperaturefor at least six months, whereas control suspensions of unmodifiedmagnetite and magnetite stabilized by mPEG-OH or mPEG-NH₂ precipitatedout in less than 24 hours in each solvent.

Example 14d

Suspensions of mPEG-DOPA stabilized nanoparticles were also found to bestable under physiologic concentrations of salt. To determine whethermPEG-DOPA could inhibit salt-induced nanoparticle aggregation, 0.3 mg ofmPEG-DOPA treated magnetite was placed in a quartz cuvette and combinedwith 0.7 ml of water (18 MΩ-cm filtered using a 0.25μ filter). Aliquotsof saturated NaCl solution (5 μl, 10 μl, 20 μl, 50 μl, 100 μl) weresequentially added to the cuvette and allowed to stand for ten minutesbefore UV-VIS spectra were taken (FIG. 15). The absorbance spectra ofmPEG-DOPA stabilized nanoparticles suspended in solutions containingincreasing NaCl concentration were nearly identical, demonstrating thatmPEG-DOPA is effective at stabilizing the nanoparticles and preventingaggregation. The peak centered at 280 nm is indicative of the catecholside chain of DOPA.

Example 14e

The procedures and techniques illustrated in examples 14a-14d can beextended to various other metal oxide or ceramic nanoparticles, as wouldbe understood by those skilled in the art made aware of this invention.Likewise, such applications of the present invention can further includeuse of a wide range of polymer-DHPD conjugates analogous to andconsistent with those compositions and variations thereof described inexamples 10b and 11b. As illustrated below in the preparation ofsemiconductor compositions, metal oxide or ceramic nanoparticles can bestabilized in situ upon formation in the presence of a polymer-DHPDconjugate of this invention.

Example 15a

Demonstrating stabilization of metal nanoparticles, commercial goldcolloid suspension (Sigma, particle size 5 or 10 nm) was placed insidedialysis tubing (M_(w) cutoff of 8000 for 5 nm and 15000 for 10 nm) anddialyzed in ultrapure water for 2-3 days to remove the sodium azidepresent in the commercial preparation. The dialyzed suspensions werethen placed into small glass vials and mPEG-DOPA added (10 mg/ml). Thesamples were allowed to stand at room temperature for approximately 2days, after which the samples were again dialyzed to remove excessmPEG-DOPA. Untreated 10 nm Au nanoparticles were unstable in thepresence of NaCl and aggregated (FIG. 16), whereas the treated Aunanoparticles remained stably suspended in the presence of aqueous NaCl(FIG. 17).

Example 15b

Various other metal nanoparticles, including but not limited to, silver,platinum and the like can be stabilized as described in the precedingexample. While stabilization was demonstrated using a representativeconjugate composition of this invention, various other compositions canbe prepared analogous to and consistent with the alternate embodimentsdescribed in Examples 10b and 11b. Comparable results can be obtained byin situ formation of the stabilized nanoparticles synthesized from thecorresponding metal precursor in the presence of a suitable, adhesiveconjugate polymer of this invention.

Example 16a

The data of this example demonstrates stabilization of semiconductornanoparticles. CdS nanoparticles (quantum dots) were prepared by astandard method based on the slow mixing of dilute Cd(NO₃)₂ and Na₂Ssolutions. Fresh stock solutions (2 mM) of Cd(NO₃)₂ and Na₂S wereprepared in nanopure water. The Na₂S solution was injected slowly into50 ml of Cd(NO₃)₂ solution using a gastight syringe at a rate of 20 μls⁻¹. The solution turned yellow with the addition of Na₂S, and after 2mL of Na₂S was injected, a yellow precipitate appeared due to theaggregation of CdS nanoparticles. The CdS precipitate was isolated anddried for further use. Using the method described above for magnetite,the dry CdS powder was dispersed in a mPEG-DOPA solution by sonicationto yield a clear yellow solution. The yellow aqueous suspension wasstored in the dark for several months at room temperature withoutvisible formation of precipitate. Control experiments performed in theabsence of polymer and in the presence of mPEG-OH or mPEG-NH₂ yieldedyellow precipitate and a clear, colorless supernatant. mPEG-DOPAstabilized CdS nanoparticles remained stably suspended in the presenceof aqueous NaCl (FIG. 18).

Example 16b

The results of this example illustrate the in situ formation ofstabilized semiconductor nanoparticles. CdS nanoparticles (quantum dots)were formed in the presence of mPEG-DOPA by slowly mixing dilutemethanolic solutions of Cd(NO₃)₂ and Na₂S. Freshly prepared stocksolutions (2 mM) of Cd(NO₃)₂ and Na₂S were prepared in methanol. 25 mgof mPEG-DOPA (PEG molecular weight=2000) was dissolved in 5 ml of 2 mMCd(NO₃)₂ in methanol, then 5 ml of a 2 mM solution of Na₂S was addedslowly with a syringe at a rate of 20 μl s⁻¹. The solution graduallyturned yellow during the addition. No yellow precipitates were observed,and dynamic light scattering revealed particles with an average diameterof 2.5 nm. Control experiments performed in the absence of polymer or inthe presence of mPEG-OH yielded yellow precipitate and a clear,colorless supernatant. Various other inorganic particulate substratescan be prepared, as would be understood by those skilled in the art,depending upon material choice and corresponding ionic substitution orexchange reaction, as carried out in the presence of an adhesivecomposition of the sort described herein.

Example 16c

The polymeric conjugate compositions of this invention can also be usedto stabilize a variety of other semiconductor materials. For instance,core-shell nanoparticles can be surface stabilized in accordanceherewith.

Example 17

The optimization experiments of Examples 17-20 were performed withmPEG-DOPA-5K. Several parameters were examined to optimize theadsorption of mPEG-DOPA onto gold from solution, including type and pHof solvent, time of adsorption, and mPEG-DOPA solution concentration.Cell attachment and spreading did not vary widely with adsorptionsolvent used. The number of cells on the substrates and their totalprojected area was not significantly different between DCM and threedifferent aqueous solutions. The substrates adsorbed in neutral, basic,and organic mPEG-DOPA solutions all possessed significantly enhancedanti-fouling properties when compared to the unmodified substrate(p<0.01). Although no differences were observed in cell attachment andspreading between the solutions, the contact angle data would supportthe use of an organic solvent in an optimal modification protocol as ameans to reduce catechol oxidation. Additionally, only the surfacemodified in DCM demonstrated significantly fewer cells on the surfaceand lower total projected cellular area.

Example 18

Cell attachment and spreading showed a strong dependence on solutionconcentration of mPEG-DOPA (FIG. 12). Above 25 mg/ml mPEG-DOPA,significantly fewer cells attached and spread on the modified substratethan on the pristine gold surface (p<0.001) and the surface modified ina 10 mg/ml solution (p<0.05). Below 10 mg/ml, there were no differencesin cell attachment and spreading compared to the unmodified substrate.There were no differences in cell attachment and spreading observedbetween surfaces modified in mPEG-DOPA solutions ranging from 25-75mg/ml when compared to each other.

Example 19

Fewer fibroblasts were observed to attach and spread with increasingduration of mPEG-DOPA adsorption, as well. Although cell attachment andspreading appeared to decrease with as little as 5 minutes of substratemodification, an adsorption time of 24 hours resulted in significantlyfewer cells attaching and spreading on the PEGylated substrate than onthe unmodified substrate (p<0.001) and substrates treated for shorterperiods (p<0.05).

Example 20

The morphology of fibroblasts cultured on both unmodified andPEG-modified surfaces was examined via electron microscopy (Hitachi 3500SEM). Fibroblasts on unmodified Au and mPEG-OH-modified Au weregenerally flat and well spread, while those cultured on mPEG-DOPAmodified Au were far less spread (FIGS. 14A-C). It should also be notedthat on the mPEG-DOPA surface, a lower number of cellular processes wereobserved than in the others, structures which contribute to celladhesion via integrins and focal adhesions. FIG. 13 illustrates thedifferences in attachment and spreading of fibroblasts on bare Au,mPEG-OH-treated Au, and Au modified with mPEG-DOPA 5K, mPEG-MAPd 2K, ormPEG-MAPd 5K under optimal conditions (50 mg/ml for 24 hours). Thesurfaces modified with DOPA-containing conjugates have significantlyless cellular adhesion and spreading than either of the other twosurfaces. The mPEG-MAP 5K modification, though, accounted for a 97%reduction in total projected cellular area and a 91% reduction indensity of cells on the surface, a far greater reduction than thatachieved by mPEG-DOPA 2K.

The differences in cellular adhesion and spreading between surfacesmodified with DOPA- and MAPd-conjugated PEG in FIG. 13 can likely beattributed to the physical characteristics of the associated PEGadlayer. Analysis of the SPR results indicates that MAPd-PEGs formthicker, more robust adlayers with a higher concentration of PEG perunit area than do the DOPA-anchored PEGs of equivalent molecular weight.The thicker adlayers resulting from MAPd-mediated PEGylation are moresuccessful in inhibiting protein adsorption and, in turn, cell adhesion.

Example 21 Synthesis of Boc-DOPA(TBDMS)₂—OSu

N-hydroxysuccinimide (NHS) (0.110 g, 0.95 mmol) was added to a solutionof Boc-DOPA(TBDMS)₂ (0.500 g, 0.95 mmol) in dry dichloromethane (DCM)(8.0 mL). The solution was stirred on an ice bath, and1,3-dicyclohexylcarbodiimide (DCC) (0.197 g, 0.95 mmol) was added undernitrogen atmosphere. The reaction was stirred for 20 minutes at 0° C.and then warmed to room temperature and stirred for an additional 4hours. The reaction mixture was filtered to remove the urea byproductand subsequently evaporated to ⅕ of its original volume. The solutionwas cooled to 4° C., allowed to sit for 2 hours to precipitate theremaining urea byproduct, filtered and evaporated to giveBoc-DOPA(TBDMS)₂—OSu as a white foam (0.567 g, 96% yield).

Example 22 Synthesis of Boc-DOPA₂(TBDMS)₄

Boc-DOPA(TBDMS)₂—OSu (0.567 g, 0.91 mmol) was dissolved in drydimethylformamide (DMF) (2.5 mL), and DOPA(TBDMS)₂ (0.405 g, 0.95 mmol)was added at once under a nitrogen atmosphere. The mixture was stirredon an ice bath, and diisopropylethylamine (DIEA) (158 μL, 0.91 mmol) wasadded dropwise via a syringe. After 20 minutes, the reaction was warmedto room temperature, stirred for an additional 17 hours, filtered (ifnecessary), diluted with ethyl acetate (EtOAc) (40 mL), transferred to aseparatory funnel, and washed with 5% aqueous HCl. The aqueous layer wasextracted back with EtOAc. The organic layers were combined and washedwith 5% aqueous HCl (3×), H₂O (1×), dried with MgSO₄, and evaporated toafford Boc-DOPA₂(TBDMS)₄ as a white foam (0.83 g, 98% yield).

Example 23 Synthesis of Boc-DOPA₂(TBDMS)₄—OSu

The procedure of Example 21 was repeated using Boc-DOPA₂(TBDMS)₄ toobtain Boc-DOPA₂(TBDMS)₄—OSu.

Example 24 Synthesis of Boc-DOPA₃(TBDMS)₆

The procedure of Example 22 was repeated using Boc-DOPA₂(TBDMS)₄—OSu toobtain Boc-DOPA₃(TBDMS)₆.

Example 25 Synthesis of DOPA₂

Boc-DOPA₂(TBDMS)₄ (0.5 g, 0.54 mmol) was dissolved in saturatedHCl/EtOAc (3 mL), and the solution was stirred under nitrogen. After 5hours, additional HCl gas was gently bubbled through the solution for 25minutes. The reaction was allowed to sit overnight, and subsequentlyconcentrated to ½ of original volume. The resulting precipitate wascollected by centrifugation, washed with cold EtOAc (3×), and dried toyield DOPA₂ as a white powder (0.15 g, 74% yield). The product wasfurther purified by preparative RP-HPLC, and characterized by ESI-MS.

Example 26 Synthesis of DOPA₃

Boc-DOPA₃(TBDMS)₆ (1.06 g, 0.79 mmol) was dissolved in saturatedHCl/EtOAc (3 mL), and the solution was stirred under nitrogen. After 12hours, additional HCl gas was gently bubbled through the solution for 30minutes, and the reaction was allowed to continue for 40 hours. More HClgas was bubbled through the solution for another 30 minutes, and thestirring was stopped. The resulting precipitate was collected bycentrifugation, washed with cold EtOAc (3×), and dried to give DOPA₃ asa white powder (0.424 g, 96% yield). The product was further purified bypreparative RP-HPLC, and characterized by ESI-MS.

Example 27 Synthesis of mPEG-DOPA₁₋₃

A solution of 0.1 M borate buffer (50 mL, pH 8.5) was degassed withargon for 20 minutes, and L-DOPA (0.197 g, 1.0 mmol) was added. Afterthe solution was stirred for 15 minutes, methoxy-terminated PEG-SPA(mPEG-SPA) 5K (0.5 g, 0.1 mmol) was added in portions, and the reactionwas allowed to stir for 3 hours. The resulting clear solution was thenacidified to pH of 1-2 with aqueous HCl, and extracted with DCM (3×).The combined organic layers were washed with 0.1 M HCl, dried over MgSO₄and concentrated. The remaining residue was dissolved in DCM andprecipitated with ethyl ether three times to afford mPEG-DOPA as a whitepowder (0.420 g, 84% yield). The product was characterized by MALDI-MSand ¹H NMR spectroscopy.

Example 28 Surface Modification

Solid metal substrates (Al, 316L stainless steel and NiTi) were groundand polished, ultimately with 0.04 m colloidial silica (Syton, DuPont).Si wafers were evaporated with either 20 nm TiO₂ or 10 nm TiO₂/40 nm Auusing an Edwards FL400 electron beam evaporator at <10⁻⁶ Torr and weresubsequently diced in 8 mm×8 mm pieces. All substrates were cleanedultrasonically for 20 minutes in each of the following: 5% Contrad70(Fisher Scientific), ultrapure H₂O, acetone, and petroleum ether.Subsequently, surfaces were further cleaned by exposure to O₂ plasma(Harrick Scientific) at 150 mTorr and 100 W for 5 minutes. To preventthe formation of a gold oxide (Au₂O₃) layer, some Au substrates were notexposed to O₂ plasma. To generate a bipolymer analog surface, glasscoverslips (Fisher Scientific) were cleaned as described above andimmersed in a 0.01% solution of poly-L-lysine (Sigma) for 5 minutes,rinsed with ultrapure H₂O, and dried under nitrogen.

In order to explore a variety of modification conditions with a minimumnumber of samples, a nine element Robust Design approach was employed.Substrates were modified under cloud point conditions by immersion inmPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄ buffered with 0.1 M MOPS at 50° C.Buffer pH, modification time, and mPEG-DOPA concentration were modifiedas shown in Table 1. Modified substrates were subsequently rinsed withultrapure H₂O and dried under a stream of nitrogen.

TABLE 1 Anchoring Adsorption Polymer Experiment Group Buffer pH TimeConcentration 1 -DOPA 3.0 1 h 0.5 mg/mL 2 -DOPA 6.0 4 h 1.0 mg/mL 3-DOPA 9.0 24 h  3.0 mg/mL 4 -DOPA₂ 3.0 4 h 3.0 mg/mL 5 -DOPA₂ 6.0 24 h 0.5 mg/mL 6 -DOPA₂ 9.0 1 h 1.0 mg/mL 7 -DOPA₃ 3.0 24 h  1.0 mg/mL 8-DOPA₃ 6.0 1 h 3.0 mg/mL 9 -DOPA₃ 9.0 4 h 0.5 mg/mL

Example 28a TiO₂ Substrates

TiO₂ substrates were modified under cloud point conditions by immersionin mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄ buffered with 0.1 MN-morpholinopropanesulfonic acid (MOPS) at 50° C. for 24 hours. Modifiedsubstrates were rinsed with ultrapure H₂O and dried under a stream ofnitrogen.

Example 28b

316L Stainless Steel (Goodfellow, Devon Pa.) was modified under cloudpoint conditions by immersion in mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄buffered with 0.1 M N-morpholinopropanesulfonic acid (MOPS) at 50° C.for 24 hours. Modified substrates were rinsed with ultrapure H₂O anddried under a stream of nitrogen.

Example 28c

Al₂O₃ (Goodfellow, Devon Pa.) was modified under cloud point conditionsby immersion in mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄ buffered with 0.1M N-morpholinopropanesulfonic acid (MOPS) at 50° C. for 24 hours.Modified substrates were rinsed with ultrapure H₂O and dried under astream of nitrogen.

Example 28d

SiO₂ (1500 Å thermal oxide, University Wafer, South Boston, Mass.) wasmodified under cloud point conditions by immersion in mPEG-DOPA₁₋₃solutions in 0.6 M K₂SO₄ buffered with 0.1 M N-morpholinopropanesulfonicacid (MOPS) at 50° C. for 24 hours. Modified substrates were rinsed withultrapure H₂O and dried under a stream of nitrogen.

Example 28e

NiTi alloy (10 mm×10 mm×1 mm) was obtained from Nitinol Devices &Components (Fremont, Calif.) and modified under cloud point conditionsby immersion in mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄ buffered with 0.1M N-morpholinopropanesulfonic acid (MOPS) at 50° C. for 24 hours.Modified substrates were rinsed with ultrapure H₂O and dried under astream of nitrogen.

Example 28f

Au (electron beam evaporated onto Si Wafer from University Wafer) wasmodified under cloud point conditions by immersion in mPEG-DOPA₁₋₃solutions in 0.6 M K₂SO₄ buffered with 0.1 M N-morpholinopropanesulfonicacid (MOPS) at 50° C. for 24 hours. Modified substrates were rinsed withultrapure H₂O and dried under a stream of nitrogen.

Example 28g

Au₂O₃ (Au samples as described in Example 28f were exposed to an oxygenplasma to form Au203) was modified under cloud point conditions byimmersion in mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄ buffered with 0.1 MN-morpholinopropanesulfonic acid (MOPS) at 50° C. for 24 hours. Modifiedsubstrates were rinsed with ultrapure H₂O and dried under a stream ofnitrogen.

Example 28h

GaAs (University Wafer, South Boston, Mass.) was modified under cloudpoint conditions by immersion in mPEG-DOPA₁₋₃ solutions in 0.6 M K₂SO₄buffered with 0.1 M N-morpholinopropanesulfonic acid (MOPS) at 50° C.for 24 hours. Modified substrates were rinsed with ultrapure H₂O anddried under a stream of nitrogen.

Example 28i

p-L-Lys surfaces were made by immersing glass coverslips (FisherScientific) in a 0.01% solution of poly-L-lysine (p-L-Lys, Sigma) for 5minutes, rinsed with ultrapure H₂O, and dried under N₂. They were thenmodified under cloud point conditions by immersion in mPEG-DOPA₁₋₃solutions in 0.6 M K₂SO₄ buffered with 0.1 M N-morpholinopropanesulfonicacid (MOPS) at 50° C. for 24 hours. Modified substrates were rinsed withultrapure H₂O and dried under a stream of nitrogen.

Example 29 Cell Adhesion

3T3 Swiss albino fibroblasts (ATCC, Manassas, Va.) of passage 12-16 werecultured normally at 37° C. and 5% CO₂ in Dulbecco's modified Eagle'smedium (DMEM) (Cellgro, Herndon, Va.) supplemented with 10% fetal bovineserum (FBS) (Celigro, Herndon, Va.), 100 g/mL penicillin, and 100 U/mLsteptomycin. Prior to cell adhesion assays, fibroblasts were harvestedusing 0.25% trypsin-EDTA, resuspended in growth medium, and counted witha hermacytometer.

General Procedure for Four-Hour Assay

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29a TiO₂ Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29b TiO₂ Substrate (Long-Term Studies)

For long-term studies on TiO₂, substrates were reseeded twice per weekat the same density as for the 4-hour assay. At periodic intervals,non-adherent cells were removed by aspirating the medium in each well.

Example 29c 316L Stainless Steel Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5M1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29d Al₂O₃ Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×1 03 cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29e SiO₂ Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29f NiTi Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29g AU Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29h Au₂O₃ Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,31,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29i GaAs Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×1 03 cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 29i p-L-Lys Substrate (4-Hour Assay)

Test substrates were prepared in 12-well tissue culture polystyreneplates with 1.0 mL DMEM with FBS for 30 minutes at 37° C. and 5% CO₂.Cells were seeded onto the substrates at a density of 2.9×10³ cells/cm²and maintained in DMEM with 10% FBS at 37° C. and 5% CO₂ for 4 hours.For the 4-hour cell adhesion assay, adherent cells were fixed in 3.7%paraformaldehyde for 5 minutes and subsequently stained with 5 μM1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI)(Molecular Probes, Eugene, Oreg.) in DMSO for 45 minutes at 37° C.

Quantitative cell attachment data was obtained by acquiring 9-16 images(depending on substrate size) from random locations on each substrateusing a Leica epifluorescent microscope equipped with a SPOT RT digitalcamera (Diagnostic Instruments, Sterling Heights, Mich.). The resultingimages were quantified in terms of total projected cellular area usingthresholding in MetaMorph. (Universal Imaging Corporation™, a subsidiaryof Molecular Devices Corporation, Downington, Pa.). The mean andstandard deviation of the measurements are reported.

Example 30 Twenty-Four-Hour Modification of Substrates and Four-HourAssay

Each surface was modified for 24 hours in a solution of 1.0 mg/mLmPEG-DOPA₃ (or mPEG-OH as a control) at 50° C. at the pH values shown inFIG. 24. A four-hour cell adhesion and spreading assay was conducted asdescribed above in Example 9. Results are shown in FIG. 24. Celladhesion resistance was conferred to all substrates treated withmPEG-DOPA₃. Cell adhesion and spreading on substrates treated withmPEG-OH did not differ from the unmodified surfaces (data not shown).

Example 31 Surfaces and Surface Preparation

Silicon wafers (WaferNet GmbH, Germany) were coated with TiO₂ (20 nm) byphysical vapor deposition using reactive magnetron sputtering (PSI,Villigen, Switzerland). Metal oxide coated wafers were subsequentlydiced into 1 cm×1 cm pieces for ex-situ ellipsometry measurements.Optical waveguide chips for OWLS measurements were purchased fromMicrovacuum Ltd. (Budapest, Hungary) and consisted of a AF45 glasssubstrate (8×12×0.5 mm) and a 200 nm-thick Si_(0.25)Ti_(0.75)O₂waveguiding surface layer. An 8 nm TiO₂ layer was deposited on top ofthe waveguiding layer under the same conditions described above for thesilicon wafers. Prior to polymer modification, TiO₂-coated siliconwafers and waveguide chips were sonicated in 2-propanol for 10 minutes,rinsed with ultrapure water, and dried under a stream of nitrogen,followed by a 3 minute exposure to O₂ plasma (Harrick Scientific,Ossining, USA) to remove all organic components from the surface. AfterOWLS measurements, waveguides were regenerated for reuse by sonication(10 minute) in cleaning solution (300 mM HCl, 1% detergent; RocheDiagnostics, Switzerland) and subsequent rinsing with ultrapure water toremove adsorbates.

Surface Modification.

Surfaces were modified by mPEG-DOPA₁₋₃, produced according to Example27, for 24 hours at a polymer concentration of 1.0 mg/ml using cloudpoint buffer (CP buffer: 0.6 M K₂SO₄ buffered to pH=6.0 with 0.1 M MOPS)at temperatures ranging from 25° C. to 50° C. After modification,substrates were rinsed with water, dried in a stream of N₂, andimmediately analyzed as described below.

X-Ray Photoelectron Spectroscopy (XPS) Measurements.

Survey and high resolution spectra were collected on a SAGE 100 (SPECS,Berlin, Germany) using a standard (non-monochromatized) AlK_(α) X-raysource operating at 325 W (13 kV, 25 mA) and a take-off angle of 0°,defined as the angle between the photoelectron detector and the surfacenormal. Pass energies of 50 eV and 14 eV were used for survey andhigh-resolution spectra, respectively. The pressure of the analysischamber remained below 2×10⁻⁸ Pa during data acquisition. All XPSspectra were referenced to the aliphatic hydrocarbon component of theC1s signal at 284.7 eV. Curve fitting was performed with CasaXPSsoftware using Shirley background subtraction and the sum of a 90%Gaussian and 10% Lorentzian function. Measured intensities (peak areas)were converted to normalized intensities by atomic sensitivity factors,from which atomic compositions of surfaces were calculated. Averagevalues obtained from three substrate replicates is reported in Tables7-8. Standard deviations were typically <10% of the mean and are omittedfor clarity.

TABLE 7 Quantitative Analysis of XPS Data for mPEG-DOPA Modified TiO₂Surfaces atomic concentration (atom %) O C O1S_(c) C1S_(A) O1S_(A)O1S_(B) C—O, C—C, C1S_(B) C1S_(C) surface Ti TiO₂ TiOH H₂O C—H C—ONHC(═O) Clean 24.3 50.9 14.1 4.1 4.5 1.2 0.9 TiO₂ mPEG- 17.9 36.8 5.213.1 2.8 23.1 1.2 DOPA₁ mPEG- 11.1 22.5 3.2 20.2 3.7 37.3 2.1 DOPA₂mPEG- 7.4 15.9 0.5 25.3 4.0 43.7 3.2 DOPA₃

TABLE 8 Atomic Ratios Calculated from XPS Data for mPEG-DOPA ModifiedTiO₂ Surfaces atomic ratio^(a) surface C/Ti O_(A)/Ti O_(B)/O_(A)C_(B)/C_(A) C_(C)/C_(B) C_(C)/C_(A) clean TiO₂ 0.27 2.10 0.28 0.33 0.420.20 mPEG- 1.52 2.06 0.14 8.42 0.052 0.42 DOPA mPEG- 3.89 2.03 0.1410.07 0.055 0.56 DOPA₂ mPEG- 6.87 2.14 0.03 11.00 0.074 0.80 DOPA₃^(a)Contributions A, B, and C are defined in Table 7.Spectroscopic Ellipsometry.

For ELM measurements, TiO₂-sputtered Si substrates were modified ex-situas described above, with the temperature of the modification solutionvaried from 25° C. to 50° C. After modification, substrates were rinsedwith H₂O, incubated at room temperature in 10 mM HEPES buffer (pH=7.4)for 48 hours, rinsed again with H₂O and dried with N₂. To examineprotein resistance, modified and unmodified substrates were exposed topure human serum for 15 minutes, rinsed with water, and dried in astream of N₂. ELM measurements were made on a M-2000D spectroscopicellipsometer (J. A. Woollam Co., Inc., Lincoln, USA) at 65°, 70°, and75° using wavelengths from 193-1000 nm prior to and immediately aftermodification, after HEPES incubation, and after serum exposure. ELMspectra were fit with multilayer models in the WVASE32 analysis softwareusing the optical properties of a generalized Cauchy polymer layer(A_(n)=1.45, B_(n)=0.01. C_(n)=0), to obtain the “dry” thicknesses ofadsorbed PEG and serum adlayers. (The “dry” or dehydrated thickness isthat measured under ambient conditions after drying with N₂.) Theaverage thickness measured from three replicates is reported in Tables9-10.

TABLE 9 Effect of Adsorption Temperature on Thickness of PEG Adlayers onTiO₂ ^(a) Adsorption Temperature (° C.) Thickness (Å) 25 10.6 ± 1.8 2813.9 ± 0.3 31 16.4 ± 1.1 34 19.4 ± 1.9 37 19.6 ± 3.5 40 22.5 ± 2.0 4524.4 ± 2.0 50 33.8 ± 4.6 ^(a)TiO₂ surfaces were exposed to mPEG-DOPA₃ (1mg/ml) for 2 h after which each surface was rinsed for 48 h in HEPES.

TABLE 10 Apparent Thickness (Å) of Organic Adlayers on TiO₂ as Measuredby Spectroscopic Ellipsometry mPEG-DOPA₃ adsorption time (min)Treatment^(a) 0 1 30 60 240 1080 Before serum exposure — 5.1 24.2 27.631.8 35.0 After serum exposure 60.2 23.4 24.7 <28.1^(b) <32.3^(b)<35.5^(b) ^(a)TiO₂ surfaces were exposed to mPEG-DOPA₃ (1 mg/ml) for0-1080 min, rinsed with water, incubated for 48 h in HEPES and thenexposed to serum for 15 min. ^(b)The net increase in adlayer thicknessafter serum exposure was less than 0.5 Å, the approximate resolution ofthe ELM technique.Optical Waveguide Lightmode Spectroscopy (OWLS).

TiO₂-coated waveguides were cleaned in 2-propanol and O₂ plasma asdescribed above. Clean waveguides were mounted in the measurement headof an OWLS110 (Microvacuum Ltd.) and stabilized for at least 48 hours atroom temperature in cloud point buffer (CP buffer: 0.6 M K₂SO₄ bufferedto pH=6.0 with 0.1 M MOPS). The stabilization period allowed for theexchange of ions at the TiO₂ surface to come to equilibrium and obtain astable baseline. To monitor polymer adsorption, mPEG-DOPA in CP bufferwas injected in stop-flow mode, followed by CP buffer to remove unboundPEG, after which the signal was allowed to stabilize. The incouplingangles, α_(TM) and α_(TE), were recorded and converted to refractiveindices (N_(TM), N_(TE)) by the manufacturer-supplied software.Real-time changes in the effective refractive index of the sensor wereconverted to adsorbed mass using de Feijter's formula. Need details ofreference for incorporation[de Feijter, 1978 #14] The refractive indexincrement, dn/dc, for each mPEG-DOPA polymer was calculated by linearinterpolation between 0.13 cm³/g for pure PEG and 0.18 cm³/g for purepoly(amino acid). For protein adsorption experiments, the temperature ofthe measurement head was equilibrated at 37° C. until the signalstabilized, after which serum was injected for 15 minutes followed byinjection of buffer. Substantial differences in adsorbed mass were notobserved with increases in serum exposure time.

Example 32 Synthesis of N-methacryloyl 3,4-dihydroxyl-L-phenylalanine

1.15 g (5.69 mmol) of Na₂B₄O₇ was dissolved in 30 ml of water. Thesolution was degassed with Ar for 30 minutes, after which 0.592 g (3.0mmol) of L-DOPA was added and stirred for 15 minutes. 0.317 g (3.0 mmol)of Na₂CO₃ was then added, the solution was cooled to 0° C., and 0.3 ml(3.0 mmol) of methacryloyl chloride was slowly added with stirring. ThepH of the solution was maintained above 9 with Na₂CO₃ during thereaction. After stirring for 1 hour at room temperature, the solutionwas acidified to pH of 2 with concentrated HCl. The mixture wasextracted with ethyl acetate three times. After washing with 0.1 N HCland drying over anhydrous MgSO₄, the solvent was removed in vacuo toyield crude light brown solid. The product was further purified byelution from a silica gel column with dichloromethane (DCM) and methanol(95:5). After evaporating the solvent, a white, sticky solid wasobtained with a product yield of 35%. ¹H NMR (500 MHz, acetone-d₆): ÿ7.1 d(1H, —NH—); 6.6-6.8 (3H, C₆H₃(OH)₂—); 5.68 s (1H, CHH═); 5.632 s(unknown peak); 5.33 s (1H, CHH═); 4.67 m (1H, —CH—); 2.93-3.1 m (2H,CH₂—); 1.877 s (3H, —CH₃).

Example 33 Synthesis of 3,4-bis(t-butyldimethylsilyloxy)-L-phenylalanine

3.60 g (24.0 mmol) of TBDMS-Cl was dissolved in 18 ml of anhydrousacetonitrile. 1.60 g (8.0 mmol) of L-DOPA was added to the solution, thesuspension was stirred and cooled to 0° C., and 3.6 ml of DBU (24.0mmol) was added. The reaction mixture was then stirred for 24 hours atroom temperature. Addition of cold acetonitrile to the reaction solutionresulted in a colorless precipitate. The precipitate was filtered andwashed with cold acetonitrile several times followed by drying invacuum. White powder was obtained with a yield of 78%. ¹H NMR (500 MHz,methanol-d); ÿ 6.7-6.9 (e H, C₆H₃(O—Si—)₂—); 3.72 (m, 1H, —CH—);2.82-3.2 (m, 2H, —CH₂—); 1.0 (d, 18H, —C(CH₃)); 0.2 (d, 12H, S₁—CH₃).

Example 34 Synthesis of3,4-bis(t-butyldimethylsilyloxy)-N-t-butyloxycarbonyl-L-phenylalanine

1.60 g (3.77 mmol) of 3,4-bis(t-butyldimethylsilyloxy)-L-phenylalaninewas added to 10 ml of water containing 0.34 g (4.05 mmol) of NaHCO₃.0.96 g (4.30 mmol) of di-t-butyl dicarbonate in 10 ml of tetrahydrofuranwas added and the reaction mixture was stirred for 24 hours at roomtemperature. After evaporation of tetrahydrofuran, 10 ml of water wasadded to the residue. The solution was acidified with dilute HCl to pHof 5 and extracted three times with ethyl acetate. After drying overanhydrous MgSO₄, the solvent was removed in vacuo. The crude product waspurified by column chromatography (silica gel; eluent; 10% methanol inDCM). A white solid was obtained with a yield of 70% after evaporatingthe eluting solvent. ¹H NMR (500 MHz, methanol-d); ÿ 6.68-6.81 (3H,C₆H₃(O—Si—)₂—); 4.28 (m, 1H, —CH—); 2.78-3.08 (m, 2H, —CH₃—); 1.4 (s,9H, —O—C(CH₃)₃); 1.0 (d, 18H, —Si—C(CH₃)₃); 0.2 (d, 12H, Si—(CH₃)₂).

Example 35 Synthesis of3,4-Bis(t-butyldimethylsilyloxy)-N-t-butyloxycarbonyl-L-phenylalaninePentafluorophenyl Ester

1 g (1.90 mmol) of3,4-bis(t-butyldimethylsilyloxy)-N-t-butyloxycarbonyl-L-phenylalanineand 0.351 g (1.90 mmol) of pentafluorophernol were dissolved in asolvent mixture of 24 ml of dioxance and 1 ml of DMF, and 0.432 g (2.10mmol) of DCC was added at 0° C. The solution was stirred for 1 hour at0° C. and for 1 hour at room temperature, after which the solution wasfiltered to remove dicyclohexylurea and evaporated in vacuo. The product4 was purified by column chromatography (silica gel; eluent;hexane/ethyl acetate=11.2). After removing the eluent, pure white,sticky solid was obtained with a yield of 55%. ¹H NMR (500 MHz, CDCl₃);ÿ 6.65-6.81 (3H, C₆H₃(O—Si—)₂—); 4.85 (m, 1H, —CH—); 3.05-3.2 (m, 2H,—CH₃—); 1.41 (s, 9H, —O—C(CH₃)₃); 1.0 (d, 18H, —Si—C(CH₃)₃); 0.2 (d,12H, Si—(CH₃)₂).

Example 36 Synthesis of N-(13′-Amino-4′,7′,10′-trioxatridecanyl)-t-butyloxycarbonyl-3′,4′-bis(t-butyldimethylsilyloxy)-L-phenylalanamide

0.869 g (1.26 mmol) of3,4-Bis(t-butyldimethylsilyloxy)-N-t-butyloxycarbonyl-L-phenylalaninepentafluorophenyl ester in 10 ml of DCM was added dropwise to a mixtureof 2.07 ml (9.44 mmol) of 4,7,10-trioxa-1,13-tridecanediamine and 1.32ml (9.44 mmol) of Et₃N in 1 ml DMF over 30 minutes at 0° C. The solutionwas stirred at room temperature for another 2 hours, and then thesolvent was removed under vacuum. The crude product was loaded ontosilica gel and eluted with DCM, 5% methanol in DCM, 10% methanol in DCM,and 15% methanol in DCM. The solvent was removed under vacuum to yield 5as a white solid. The yield was 63%. ¹H NMR (500 MHz, acetone-d₆); ÿ7.38 (m, 1H, —CONH—); 6.60-6.80 (3H, C₆H₃(O—Si—)₂—); 5.26 (m, 1H,—CONH—); 4.30 (m, 1H, —CH—); 3.4-3.8 (m, 12H, —CH₂O—; 3.03-3.4 (m, 4H,—CH₂—NH—, —CH₂—NH₂); 2.78-3.02 (m, 2H, —CH₂—); 2.0 (m, 2H, —CH₂—); 1.7(m, 2H, —CH₂—); 1.39 (s, 9H, —O—C(CH₃)₃); 1.0 (d, 18H, Si—C(CH₃)₃); 0.2(d, 12H, Si—C(CH₃)₂).

Example 37 Synthesis ofN-(13-(N′-t-Butyloxycarbonyl-L-Amino-3,4′-bis(t-butyldimethylsilyloxy)-4,7,10-trioxatridecanyl)-methacrylamide

0.57 g (0.79 mmol) ofN-(13′-Amino-4′,7′,10′-trioxatridecanyl)-t-butyloxycarbonyl-3′,4′-bis(t-butyldimethylsilyloxy)-L-phenylalanamideand 0.166 ml (1.18 mmol) of Et₃N were dissolved in 5 ml of anhydrouschloroform, to which 0.176 ml (I 0.18 mmol) of methacrylic anhydride wasadded. The solution was stirred at room temperature for 3 hours, thensolvent was removed in vacuo. Pure 6 was obtained by columnchromatography (silica gel; eluent: ethyl acetate) as a white, stickysolid with a yield of 61%. ¹H NMR (500 MHz, CDCl₃); ÿ 6.60-6.80 (3H,C₆H₃(O—Si—)₂—); 6.40 (m, 1H, —CONH—); 5.71 s (1H, CHH═); 5.30 s (1H,CHH═); 5.096 (m, 1H, —CONH—); 4.21 (m, 1H, —C H—); 3.2-3.65 (m, 16H,—CH₂O, —CH₂—NH—CH₂—NH₂); 2.80-2.99 (m, 2H, —CH₂—); 1.96 s (3H, —CH₃);1.81 (m, 2H, —CH₂—); 1.68 (m, 2H, —CH₂—); 1.40 (s, 9H, —O—C(CH₃)₃); 1.0(d, 18H, Si—C(CH₃)₃); 0.2 (d, 12H, Si—C(CH₃)₂).

Example 38 Synthesis ofN-(13-(N′-t-Boc-L-3′,4′dihydroxylphenylalaninamido)-4,7,10-trioxatridecanyl)-methacrylamide

To a 10 ml round bottom flash were added 0.344 g (0.433 mmol) ofN-(13-(N′-t-Butyloxycarbonyl-L-Amino-3′,4′-bis(t-butyldimethylsilyloxy)-4,7,10-trioxatridecanyl)-methacrylamide,3 mL of THF, and 0.137 g (0.433 mmol) of TBAF. The solution was stirredat room temperature for 5 minutes, then 3 ml of 0.1 N HCl was added. Thesolution was extracted three times with DCM, after which the solvent wasevaporated in vacuum. 7 was obtained as a white solid by columnchromatography (silica gel; eluent: 7% methanol in DCM) with a yield of63%. ¹H NMR (500 MHz, acetone-d₆); ÿ 7.90 (m, 1H, —CONH—); 7.23-7.40 (d2H, C₆H₂(OH)₂—); 6.56-6.76 (3H, C₆H₂(OH)₂—; 5.930 (m, 1H, —CONH—); 5.71s (1H, CHH═); 5.30 s (1H, CHH═); 4.20 (m, 1H, —CH—); 3.1-3.60 (m, 16H,—CH₂O, —CH₂—NH—, —CH₂—NH₂); 2.70-2.95 (m, 2H, —CH₂—); 1.96 s (3H, —CH₃);1.78 (m, 2H, —CH₂—); 1.65 (m, 2H, —CH₂—); 1.39 (s, 9H, —O—C(CH₃)₃).

Example 39 Synthesis of PEG-Diacrylate (PEG-DA)

40 g (5 mmol) of PEG was dried by azeotropic evaporation in benzene andthen dissolved in 150 mL of DCM. 4.18 mL (30 mmol) of Et₃N and 3.6 mL(40 mmol) of acryloyl chloride was added to the polymer solution. Themixture was refluxed with stirring for 5 hours and allowed to cool atroom temperature overnight. Ether was added to the mixture to form afaint yellow precipitate. The crude product was then dissolved insaturated NaCl solution, which was heated to 60° C. to form two layers.DCM was added to the top layer and MgSO₄ was added to remove moisture.After filtration of MgSO₄, the volume of the solvent was reduced invacuum and the sample was precipitated in ether. The final product wasdried in vacuum and stored at −15° C. The yield was 75%. ¹H NMR (500MHz, D₂O): δ 6.47 (d, 1H, CHH═C—); 6.23 (m, 1H, C═CH—C(═O)—O—); 6.02 (d,1H, CHH═C—); 4.35 (m, 2H, —CH₂—O—C(═O)—C═C); 3.23-3.86 (PEG CH₂)

Example 40 Photopolymerization of PEG-DA

Precursor solutions of PEG-DA, 1, 7, and photoinitiator were preparedand mixed immediately before photopolymerization. Stock solutions ofPEG-DA (200 mg/mL) and 1 (40 mg/mL) were dissolved in N₂-purgedphosphate buffered saline (PBS, pH 7.4), where 7 (60 mg/mL) wasdissolved in 50:50 PBS/95% ethanol previously purged with N₂. To preparethe final polymerization mixture, solutions of 1 or 7 were combined withPEG-DA to achieve a final concentration of PEG-DA and DHPD derivativesof 150 mg/mL. 100 μL of mixture was then added to a disc-shaped mold(100 μL, diameter=9 mm, depth=2.3 mm, Secure Seal® SA8R-2.0, Grace BioLab, Inc., OR) and irradiated for up to 20 minutes either with an UVlamp (Black Ray® Lamp, 365 nm, Model UVL-56, UVP, CA) or a blue lightlamp (VIP®, 400-500 nm, BISCO Inc., IL). For UV initiated photocuring,DMPA (600 mg/mL in VP) was added to the polymeric solution to make afinal concentration of 34 mM. Visible light-induced curing was performedusing either CQ (100 mg/mL in VP, final concentration=150 mM) with DMAB(30 mg/mL in VP, final concentration=151 mM), or FNa₂ (188 mg/mL in PBS,final concentration=2 mM) with AA (100 mg/mL in PBS, finalconcentration=17 mM) as the photoinitiator. The final VP concentrationwas adjusted to be between 135 and 300 mM.

After irradiation, the gels were blotted with filter paper to remove theliquid surface layer and weighed. Percent gel conversion was thendetermined by dividing the weight of the gel by the weight of 100 μL ofthe precursor solution.

Example 41 Determining DOPA Incorporation

The amount of DOPA incorporated into the photopolymerized gel wasdetermined using a modification of the calorimetric DOPA assay developedby Waite and Benedict. Photocross-linked gels were stirred in 3 mL of0.5 N HCl to extract DOPA monomers that were not incorporated into thegel network. 0.9 mL of the nitrite reagent (1.45 M sodium nitrite and0.41 M sodium molybdate dihydrate) and 1.2 mL of 1 M NaOH were added to0.9 mL of the extraction solution, and the absorbance (500 nm) of themixture were recorded using a Hitachi U-2010 UV-Vis spectrophotometerwith 2 to 4 minutes of NaOH addition. Standard curves were constructedusing known 1 to 7 concentrations.

Example 42 Mechanical Test

Hydrogels were formed in the shape of a hemisphere by loading 25 μL ofthe polymer mixture onto a glass slide treated with1H,1H,2H,2H-perfluorooctyltrichlorosilane. Gels were irradiated for 10minutes, dialyzed in 0.15 M HCl for at least 24 hours to extractunincorporated DOPA monomers, and then equilibrated in PBS for greaterthan 15 minutes prior to testing. To determine the gel modulus,hemispherical gel caps were attached to one end of a steel cylinder(diameter=6 mm, length=30 mm) using superglue. The other end of thecylinder was attached to a piezoelectric stepping motor (IW-701-00,Burleigh Instruments, N.Y.) aligned in series with a 50 g loadtransducer (FTD-G-50, Schaevitz Sensors, Va.) with a resolution ofapproximately 0.1 mN. A fiber optic displacement sensor (RC100-GM2OV,Philtec, Inc., MD) measured the axial movement of the steel rod. ATiO₂-coated Si wafer was positioned below the hydrogel, and the Tio₂surface was flooded with PBS in order to maintain the hydration of thegel. The indenter was advanced at 5 μm/s until a maximum compressiveload of 4 mN was measured.

Elastic moduli were calculated by assuming Hertzian mechanics for thespecific case of non-adhesive contact between an incompressible elastichemisphere and a rigid plane, in which case the Hertzian relationshipbetween load (P_(h)) and displacement (δ_(h)) becomes:

$\begin{matrix}{P_{h} = {\frac{16R^{1/2}E}{9}\delta_{h}^{3/2}}} & (1)\end{matrix}$where R and E are the radius of curvature and the elastic modulus of thehemispherical gel, respectively. The radius of curvature of the gels wasdetermined from height and width measurements obtained from a photographof the gel.

Example 43 Chemical Oxidation of PEG-DOPA into a Hydrogel

4-arm-PEG-amine (PEG-(NH₂)₄, M _(w)=10,000) was purchased from SunBio,Inc. (Walnut Creek, CAv) while linear PEG-bis-amine (PEG-(NH₂)₂, M_(w)=3,400) and methoxy-PEG-amine (mPEG-NH₂, M _(w)=5,000) werepurchased from Shearwater Polymers, Inc. (Huntsville, Ala.). Sephadex®LH-20 was obtained from Fluka (Milwaukee, Wis.). N-Boc-L-DOPAdicyclohexylammonium salt, sodium periodate (NaIO₄), mushroom tyrosinase(MT, EC 1.14.18.1), and horseradish peroxidase (HRP, EC 1.11.1.17) wereacquired from Sigma Chemical Company (St. Louis, Mo.). Triethylamine(Et₃N), hydrogen peroxide (30 wt %, H₂O₂), sodium molybdate dihydrate,and sodium nitrite were purchased from Aldrich Chemical Company(Milwaukee, Wis.). L-Dopa was purchased from Lancaster (Windham, N.H.).1-Hydroxybenzotriazole (HOBt) was obtained from Novabiochem Corp. (LaJolla, Calif.) and O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluroniumhexafluorophosphate (HBTU) was acquired from Advanced ChemTech(Louisville, Ky.).

Synthesis of DOPA-Modified PEG

Linear and branched DOPA-modified PEG's containing up to four DOPAendgroups were synthesized using standard carbodiimide couplingchemistry as described below. The structure of the four DOPA-modifiedPEG's are shown in FIG. 1.

Synthesis of PEG-(N-Boc-DOPA)₄, I. PEG-(NH₂)₄ (6.0 g, 0.60 mmoles) wasreacted with N-Boc-L-DOPA dicyclohexylammonium salt (4.8 mmoles), HOBt(8.0 mmoles), and Et₃N (8.0 mmoles) in 60 mL of a 50:50 mixture ofdichloromethane (DCM) and dimethylformamide (DMF). HBTU (4.8 mmoles) in30 mL of DCM was then added and the coupling reaction was carried outunder argon at room temperature for one hour. The solution wassuccessively washed with saturated sodium chloride solution, 5% NaHCO₃,diluted HCl solution, and distilled water. The crude product wasconcentrated under reduced pressure and purified by columnchromatography on Sephadex® LH-20 with methanol as the mobile phase. Theproduct was further purified by precipitation in cold methanol threetimes, dried in vacuum at room temperature, and stored under nitrogen at−20° C. ¹H NMR (500 MHz, CDCl₃/TMS): δ 6.81-6.77 (m, 2H, C₆H₂(OH)₂—),6.6 (d, 1H, C₆H₂H(OH)₂—), 6.05 (br, s, 1H), 5.33 (br, s, 1H), 4.22 (br,s, 1H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 3.73-3.41 (m, PEO), 3.06 (m, 2H,PEO-CH₂—N—C(O)—), 2.73 (t, 2H, C₆H₃(OH)₂—CH₂—CH—), 1.44 (s, 9H,(CH₃)₃C—). GPC-MALLS: M _(w)=11,900, M _(w)/ M _(n)=1.01.

Synthesis of PEG-(DOPA)₄, II. 3.0 g of I (0.25 mmoles) was dissolved in15 mL of DCM at room temperature. 15 mL of TFA was added to the mixtureto react for 30 minutes under argon. After evaporating the solvent in arotary evaporator, the product was precipitated with cold methanol threetimes, dried in vacuum at room temperature, and stored under nitrogen at−20° C. ¹H NMR (500 MHz, D₂O): δ 6.79 (d, 1H, C₆H₂H(OH)₂—), 6.66 (s, 1H,C₆H₂H(OH)₂—), 6.59 (d, 1H, C₆H₂H(OH)₂—), 4.00 (t, 1H,C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 3.70-3.34 (M, PEO), 3.24 (m, 2H,PEG-CH₂—N—C(O)—), 3.01-2.88 (m, 2H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—).GPC-MALLS: M _(w)=11,400, M _(w)/ M _(n)=1.02.

Synthesis of PEG-(N-Boc-DOPA)₂, III. PEG-(NH₂)₂ (5.0 g, 1.5 mmoles),N-Boc-L-DOPA dicyclohexylammonium salt (5.9 mmoles), HOBt (9.8 mmoles),and Et₃N (9.8 mmoles) were dissolved in 50 mL of a 50:50 mixture of DCMand DMF. HBTU (5.9 mmoles) in 25 mL of DCM was then added, and thereaction was carried out under argon at room temperature for 30 minutes.Recovery and purification of the product was performed as describedabove for I. ¹H NMR (500 MHz, CDCl₃/TMS): δ 6.81-6.77 (m, 2H,C₆H₂(OH)₂—), 6.59 (d, 1H, C₆H₂H(OH)₂—), 6.05 (br, s, 1H), 5.33 (br, s,1H), 4.22 (br, s, 1H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 3.73-3.42 (M, PEO),3.06 (m, 2H, PEO-CH₂—N—C(O)—), 2.74 (t, 2H,C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 1.44 (s, 9H, (CH₃)₃CO—). GPC-MALLS: M_(w)=4,600, M _(w)/ M _(n)=1.02.

Synthesis of methoxy-PEG-(N-Boc-DOPA), IV. mPEG-NH₂ (2.0 g, 0.40mmoles), N-Boc-L-DOPA dicyclohexylammonium salt (0.80 mmoles), HOBt (1.3mmoles), and Et₃N (1.3 mmoles) were dissolved in 20 mL of a 50:50mixture of DCM and DMF. HBTU (0.80 mmoles) in 10 mL of DCM was thenadded, and the reaction was carried out under argon at room temperaturefor 30 minutes. Recovery and purification of the product was performedas described above for I. ¹H NMR (500 MHz, CDCl₃/TMS): δ 6.81-6.60 (m,3H, C₆H₃(OH)₂—), 6.01 (br, s, 1H, OH—), 5.32 (br, s, 1H, OH—), 4.22 (br,s, 1H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 3.73-3.38 (m, PEO), 3.07 (m, 2H,PEO-CH₂—NH—C(O)—), 2.73 (t, 2H, C₆H₃(OH)₂—CH₂—CH(N—)—C(O)N—), 1.44 (s,9H, (CH₃)₃C—), 1.25 (s, 3H, CH₃CH₂O—). GPC-MALLS: M _(w)=6,100, M _(w)/M _(n)=1.02.

DOPA Content Determination

The DOPA content of the DOPA-modified PEGs was determined by integrationof relevant peaks in the ¹H NMR spectrum, and by a colorimetric DOPAassay. In the NMR method, the DOPA content was measured by comparing theintegral value of Boc methyl protons at δ=1.44 to the PEG methyleneprotons at δ=3.73-3.38. The DOPA assay was based on the previouslydescribed method of Waite and Benedict. Briefly, PEG-DOPA aqueoussolutions were treated with nitrite reagent (1.45 M sodium nitrite and0.41 M sodium molybdate dihydrate) followed by the addition of excessNaOH solution. The absorbance (500 nm) of the mixture was recorded usinga Hitachi U-2010 UV/vis spectrophotometer, within 2 to 4 minutes of NaOHaddition. A standard curve was constructed using solutions of known DOPAconcentration.

Formation of PEG-DOPA Hydrogels

To form PEG-DOPA hydrogels, sodium periodate (NaIO₄), horseradishperoxidase and hydrogen peroxide (HRP/H₂O₂), or mushroom tyrosinase andoxygen (MT/O₂) were added to solutions of PEG-DOPA (200 mg/mL) inphosphate buffered saline (PBS, pH 7.4). For gelation induced by MT, thePBS was sparged with air for 20 minutes prior to adding MT. Gelationtime was qualitatively determined to be when the mixture ceased flowing,as measured by inversion of a vial containing the fluid.

Oscillatory Rheometry

Oscillatory rheometry was used to monitor the process of gelation and todetermine the mechanic properties of the hydrogels. Cross-linkingreagent was added to aqueous solution of PEG-DOPA and the well-mixedsolution was loaded onto a Bohlin VOR rheometer. The analysis wasperformed at a frequency of 0.1 Hz, a strain of 1%, and a 30 mm diametercone and plate fixture with a cone angle of 2.5°.

Spectroscopic Evaluation of DOPA Oxidation

DOPA-modified PEG was dissolved in 10 mM PBS solution (bubbled withargon for HRP/H₂O₂ and NaIO₄ or air for MT experiments). After addingthe oxidizing reagent, the time-dependent UV/vis spectra of the solutionwere monitored at wavelengths from 200 to 700 nm at a scan rate of 800nm/min. All samples were initially blanked against PBS buffer andrecorded at room temperature using a Hitachi U-2010 UV/visspectrophotometer.

Molecular Weight Analysis

Molecular weights were determined by GPC-MALLS on a DAWN EOS (WyattTechnology) using Shodex-OH Pak columns in an aqueous mobile phase (50mM PBS, 0.1 M NaCl, 0.05% NaN₃; pH=6.0) and a Optilab DSP (WyattTechnology) refractive index detector. For molecular weightcalculations, the experimentally determined dn/dc value of IV (0.136)was used.

Example 44 Materials and Methods

Tip Modification

Before the surface modification of silicon nitride (Si3N4) tips,cleaning procedures were performed using O₂ plasma (name of a machine)for 3 min and subsequently they were transferred to a piranha solution(sulfuric acid:H₂O₂=8:2) for 30 min. They moved to 20% (v/v)3-aminopropyltrimethoxysilane in toluene to be functionalized withamines for 30 to 60 min after rinsing with H₂O. Two polyethylene glycol(PEG) derivatives were chosen for PEGylation on the AFM tips:mPEG-N-hydroxy succinimide (NHS) (Mw 2000) and Fmoc-PEG-NHS (Mw 3400)(Nektar Inc.). Mixture (Fmoc-PEG-NHS:mPEGNHS=1:5-10, 5 mM) of PEGs wereprepared in 50 mM sodium phosphate buffer, 0.6 M K2SO4, pH 7.8 andchloroform. PEGylation reactions were conducted sequentially first in asodium phosphate buffer at 40° C. and subsequently in chloroform for 3hrs in each step. The reason to use PEG mixture is to prevent multipleDOPA binding on TiO2. Fmoc-PEG-NHS provides an amine for Boc-DOPAconjugation after Fmoc cleavage. Piperidine (20% v/v in NMP) was used todeprotect Fmoc for 5 min and subsequently cantilevers were transferredto BOP/HOBt/DOPA (a molar ratio of 1:1:1, final 8 mM in NMP) solutionwith 10 μL DIPEA. The same procedure was used for Tyrosine modification.

AFM Experiment

All data were collected in AFM instrument (Asylum Research, SantaBarbara, Calif.) on top of an inverted Nikon microscope. The springconstant (around 45, 100, and 300 pN/nm by manufacture's information) ofan individual cantilever was calibrated by applying the equipartitiontheorem to the thermal noise spectrum (S1). A drop of water was appliedto a pre-cleaned (sonication in organic solvent and O₂ plasma) TiO2surface. Force-distance curves containing PEG elasticity and contourlength were selected for further statistical analysis. For theDOPAquinone experiments, all experiments are done in 20 mM Tris, pH 9.8.

Dynamic Force Experiments

Loading rate dependent force measurement revealed the energy landscapeof DOPA binding (17). A slope (=kBT/xb) of the linear plot (force vs.1n(loading rate)) determines the distance of energy barrier xb along theapplied force axis. The binding energy barrier is calculated by theforce of logarithmic intercept at zero loading rate from the forcetransition occurred by pulling rate change and xb from the slope.Silicon nitrite AFM cantilevers (Bio-Levers, Olympus, Japan) were usedbecause of their small string constants (˜5 pN/nm and ˜28 pN/nm). Thelowest loading rate of 2 nN/sec in our study was achievable using thepulling rate of 400 nm/sec and the cantilever (˜5 pN/nm). The highestloading rate (1500 nN/sec) was produced by 5 μm/sec operation ofpiezoelectric device and the use of stiff cantilever (300 pN/nm, Veeco).Surface characterization Surfaces were analyzed by X-ray photoelectronmicroscopy (XPS), (Omicron, Taunusstein Germany) equipped with anomochromated Al Kα (1486.8 eV) 300 W X-ray source and an electron gunto eliminate charge build-up. Silicon nitride surfaces (0.7×0.7 cm2)prepared in the high temperature chamber (ask to Keun Ho) were cleanedand modified as the same procedures described in AFM tip modification.The photoelectron signal from carbon 1s orbital was the major indicatorfor surface modification considering all abundant species of Si, O, andN in Si3N4 surfaces.

While the principles of this invention have been described in connectionwith specific embodiments, it should be understood clearly that thesedescriptions are added only by way of examples and are not intended tolimit, in any way, the scope of this invention. For instance, thepresent invention can enhance the adhesive properties of a wide varietyof polymeric compositions, whether or not capable of hydrogelation.Likewise, the present invention can be used with various other synthetictechniques well known to those skilled in the art to functionally modifya particular polymeric component for a subsequent coupling andpreparation of the corresponding DOPA conjugate. Other advantages,features and benefits will become apparent from the claims filedhereinafter, with the scope thereof as determined by their reasonableequivalents and as would be understood by those skilled in the art.

x

What is claimed is:
 1. A dihydroxyphenyl (DHPD) adhesive compound of theformula

wherein n has a value of 1, 2, or 3; and wherein P is: (a) substantiallya poly(alkyleneoxide) having the structure: —(CHR₃CHR₄O)_(m)-A₄, whereinR₃ and R₄ are separately and independently H or CH₃; m has a value inthe range of between 1 and about 250; and A₄ is —NH₂, —COOH, —OH, —OCH₃,—SH, —H, or a protecting group; or (b)

wherein R₅ is H, or a C₁₋₆ lower alkyl.
 2. A DHPD as in claim 1 whereinthe poly(alkylene oxide) is a block copolymer of ethylene oxide andpropylene oxide.
 3. A coated medical device comprising a device, and acoating, the coating comprising the composition of claim
 1. 4. Thecoated medical device of claim 3, wherein the device is selected fromthe group consisting of stents and pacemakers.
 5. The coated medicaldevice of claim 3, wherein the coating is biodegradable.
 6. Adihydroxyphenyl (DHPD) adhesive compound of the formula:

wherein A₁ is a protecting group; and wherein A₂ is substantially apoly(alkylene oxide) having the structure: (a) —NHCH₂(CHR₃CHR₄O)_(m)-A₄,wherein R₃ and R₄ are separately and independently —H or —CH₃; m has avalue in the range of between 1 and about 250; and A₄ is —NH₂, —COOH,—OH, —OCH₃, —SH, —H, a protecting group, or —CH₂CH₂CH₂NH—Y, wherein Y isselected from the group consisting of —H, a protecting group, and

wherein R₅ is H, or a C₁₋₆ lower alkyl; or (b)—NHCH₂CH₂(OCHR₃CHR₄)_(m)-A₄, wherein R₃ and R₄ are separately andindependently —H or —CH₃—; m has a value in the range of between 1 andabout 250; and A₄ is —NH₂, —COOH, —OH, —OCH₃, —SH, —H, or a protectinggroup.
 7. The adhesive compound of claim 1, wherein P is substantiallythe poly(alkylene oxide) having the structure: —(CHR₃CHR₄)_(m)-A₄,wherein R₃ and R₄ are separately and independently H or CH₃; m has avalue in the range of between 1 and about 250; and A₄ is —NH₂, —COOH,—OH, —OCH₃, —SH, —H, or a protecting group.
 8. The adhesive compound ofclaim 1, wherein P is

wherein R₅ is H or a C₁₋₆ lower alkyl.
 9. The adhesive compound of claim6, wherein A₂ is substantially the poly(alkylene oxide) having thestructure —NHCH₂CH₂(OCHR₃CHR₄)_(m)-A₄, wherein A₄ is —OCH₃.
 10. Theadhesive compound of claim 6, wherein A₂ is substantially thepoly(alkylene oxide) having the structure —NHCH₂(CHR₃CHR₄O)_(m)-A₄,wherein A₄ is —CH₂CH₂CH₂NH—Y, and wherein Y is